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Patients with multiple chronic conditions consume over 40% of health care resources. The si-
loed nature of the health care system exacerbates these costs, and integrated care solutions are 
required to adequately meet their needs. However, such integrated multidisciplinary ap-
proaches are seen as costly. Therefore, costing care for patients with multiple chronic condi-
tions becomes important to support health care professionals, management, and policy makers 
understand the true financial impact of integrated multidisciplinary care. 
Aim: 
The aim of this thesis is to explore how Time-Driven Activity-Based Costing (TDABC) can 
be applied to capture and compare the cost of integrated multidisciplinary versus traditional 
siloed care processes for patients with multiple chronic conditions. 
Method: 
This thesis is comprised of four studies. Study I was a systematic review performed according 
to the PRISMA statement and used qualitative methods to analyze data through content analy-
sis. Studies II to IV were based on a randomized controlled trial CareHND (NCT03362983). 
Study II used descriptive statistics to describe patient diagnostic data, Charlson Comorbidity 
Index scores, and performed a comparison of care utilization patterns between integrated mul-
tidisciplinary care and traditional care. Study III adopted a mixed-methods approach to perform 
a TDABC analysis of integrated multidisciplinary care. Study IV expanded on Study III to 
compare the costs of integrated multidisciplinary care to that of traditional siloed care. 
Findings: 
Study I found that TDABC is an efficient and accurate tool for costing processes in health care, 
but has not been demonstrated to effectively cost care across the care continuum. Study II found 
that patients with multiple chronic conditions experience care that is characterized by high vol-
ume and high variation, and no difference in care utilization was detected when comparing 
integrated multidisciplinary care to traditional siloed care. The TDABC cost analysis in Study 
III successfully estimated the outpatient care costs for patients with multiple chronic condi-
tions.  Study IV found that the integrated multidisciplinary care center saved a hospital an av-
erage of 5,098.00 € per patient per year. 
Discussion: 
This thesis demonstrates how TDABC can be applied to capture and compare costs of pro-
cesses for patients with multiple chronic conditions. More broadly, this thesis demonstrates 
how to conceptualize and evaluate real-world care pathways for patients with multiple chronic 
conditions in order inform actionable changes to clinical management within hospitals. This 
thesis lays the groundwork for empowering hospitals and other providers to incorporate finan-
cial analyses into their evidence development, quality improvement, and decision making, and 
to contribute to the wider financial and economic systems in health care. 
Conclusion: 
This thesis demonstrates that a hospital-based integrated multidisciplinary care approach to a 
complex medical condition makes economic sense for the hospital and the system. The 
TDABC approach developed in this thesis project brought to light a set of core capacities which 
can be prioritized in future quality improvement efforts. Through these core capacities, clinical 
organizations will hopefully become empowered to make wise, value-driven decisions that will 
serve as the new incentive for organizational improvement. Information that demonstrates 
value delivery will make financial needs clear to managers and policy makers, who in turn 
should understand that evidence-based investment in care facilities and services will ultimately 
demonstrate a return, benefiting not only IMD-Care patients, but also the larger populations 
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As a health economist, I came to realize that cost figures used to inform health care systems 
are often generated on the aggregate level and designed to inform policy decisions with respect 
to remuneration and health economic evaluations of treatments, technologies and programs. 
However, the validity of these cost estimates was often the big pink elephant in the room that 
those in the health economic profession tend to ignore. How relevant are these cost estimates 
in the context of care delivery? Is this not the most important question with respect to cost, if 
we are to begin to get a handle on the consistent and unmanageable rise of health care costs 
that has become so inherent to health care systems in general? 
This question became even more apparent when I began my doctoral thesis. We originally set 
out to perform a health-economic evaluation for a multi-disciplinary care center. The purpose 
of this evaluation was unique in that it was intended as much to inform the organizational con-
text in which it was performed, as it was intended to inform the broader health care system 
regarding multi-disciplinary care. However, we quickly learned that the state of the art of cost-
ing care delivery within hospitals was poorly equipped to inform evaluations intended to inform 
care delivery itself, aside from wider policy initiatives. Further, policy initiatives that were in-
tended to incentivize providers to control costs led to unexpected and often counterproductive 
provider behaviors. 
The thesis stands upon the belief that providers want to work with other professionals within 
the health care system in order to control the costs of care. This work is intended to empower 
care providers with the tools and theoretical understanding required to begin collaborating with 








2.1 RATIONALE FOR THE THESIS: THE COST CRISIS IN HEALTH CARE     
INVOLVES PATIENTS WITH MULTIPLE CHRONIC CONDITIONS 
As health care technologies and treatments improve, people live longer. Patients are now sur-
viving chronic conditions long enough to develop several of these over their lifetime. As result, 
most people over 65 years old deal with multiple chronic conditions (MCC). In the United 
States, patients with at least five MCCs account for 12% of the population (Buttorff et al., 
2017), but they consume 41% percent of all health care resources (Buttorff et al., 2017). In 
Sweden, this group is responsible for 50% of all hospital inpatient days (Welfare, 2007). MCC 
patients consume the majority of hospital resources (Clarke et al., 2017, Lehnert et al., 2011, 
OECD, 2011), and hospitals account for between 30% and 50% of national health care ex-
penditure in countries that form the Organization for Economic Cooperation and Development 
(OECD/European Union, 2018).  
In response, health care policies have been implemented to mitigate the situation. These pri-
marily involve third-party payers incentivizing care providers to minimize waste and control 
costs, using tools that include gatekeeping, global budget negotiation, priority setting, pay-for-
performance, and bench marking (OECD, 2010). Providers work to meet these expectations, 
but they may react to incentives unpredictably and occasionally with behaviors that are coun-
terproductive from a systems perspective (Sturmberg et al., 2012). Meanwhile, aging popula-
tions, long-term care, technological innovations, and increasing prevalence of MCCs continue 
to drive up costs (OECD, 2011, OECD, 2017, Norbeck, 2013).  
This thesis builds on innovative clinical management and cost-accounting theory in health care 
management to empower health care providers and organizations to cost care for MCC patients, 
taking a vital step forward in gaining control of the economic impact of their clinical decision 
making. 
2.2 POSITIONING OF THE THESIS 
The project described in this thesis was highly empirical in nature; based on real world appli-
cations of theories and frameworks. The doctoral thesis is positioned within the fields of ac-
counting and health care management, but pulls some from the fields of health economics and 
health policy. While these fields are broad, this thesis focuses on the sub-fields of clinical man-
agement, clinical quality improvement, and cost-accounting in health care. The thesis became 
seated in these fields through the need to evaluate costs within an integrated care clinic for 
MCC patients. The nature of this topic demanded the inclusion of these academic disciplines 








3.1 A STUCK HEALTH CARE SYSTEM 
Controlling health care spending has become a central aim for policy makers (Berwick et al., 
2008), but care providers struggle to meet policy expectations. Several systematic reviews of 
the literature exploring the impact of financial incentives on quality and cost have found no 
measurable effect, and sometimes negative effects (Heider and Mang, 2020, Mandavia et al., 
2017). These included salary adjustments, fee for service incentives, bonus payments, bundled 
payments, pay for performance, revenue sharing through participation in capitated plans, and 
accountable care organizations. The diverse range of incentives combined with the need to 
solve the cost challenge only exacerbated the problem because changing financial incentives 
within health care systems are expensive and the consequences are often impossible to estimate 
or asses (Heider and Mang, 2020).  
The providers do not deal with the uncontrollable rise in system costs every day, but instead 
are focused on the managerial and clinical day-to-day challenges and issues; including devel-
oping strategies to align the incentives of policy makers with staff motivations (Korlén et al., 
2017). They receive their budgets and finances according to the policies set by decision makers, 
and work to report appropriately to minimize costs. Hospital management controls provider 
costs through annual budget setting for clinics and departments, so that providers will adjust 
existing care delivery practices to accommodate the new financial conditions (Korlén et al., 
2017). 
A large proportion of the literature regarding the challenges of cost accounting in health care 
focuses on properly reporting costs in order to inform tariff setting, bench-marking, budgeting, 
and performance management (Chapman et al., 2016). All of these are methods for reporting 
purposes that are useful to decision makers, but are not relevant on an operational level. Granted 
cost information is discussed within the context of targeted cost improvement plans and service 
redesign (Chapman et al., 2016). However, target cost improvement plans are designed to meet 
targets formulated at political levels (Storkholm et al., 2017), and service redesign is often lim-
ited to service line selections (Chapman et al., 2016). More sophisticated service redesign ap-
proaches require micro-costing of clinical condition-specific processes, a requirement often 
regarded as heavily resource intensive, making it impractical for costing all resources in care 
delivery (Drummond, 2005, Barnett, 2009). 
This prioritization on reporting manifests itself in practice. Controllers in hospitals focus a large 
proportion of their work time on reporting, and cost-accounting infrastructures are largely de-
signed for reporting purposes. For internal financial decision making, hospitals commonly use 
volume-based cost-accounting systems, where resources are allocated to care delivery based 
on volumes of services delivered (Heider and Mang, 2020). Volume-based cost estimates are 
practical for budgetary purposes, but these estimates are not relevant to providers for clinical 
decision making, as they lack the information needed to understand the economic conse-
quences of the decisions they make. Instead, the only response providers can make to optimize 
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their performance is to adjust their existing approach to care to accommodate changes in 
budget. While it may seem that policy makers are to blame for putting undue pressure on pro-
viders, they are nevertheless compelled to incentivize providers because they are responsible 
for taking whatever action necessary to understand and control the cost of care. 
A core principle in management is that you cannot improve what you haven not measured. 
Traditional volume-based cost accounting infrastructures do not measure where costs are in-
curred in the treatment of patient clinical conditions, but instead distribute costs equally among 
volumes of cost-relevant services delivered. Condition-specific micro-costing approaches have 
been demonstrated to be well-suited for the complexity of health care (Kaplan and Porter, 2011, 
Hennrikus et al., 2012), and are the best costing approaches for informing service redesign and 
process improvement (Heider and Mang, 2020). Some national health care systems have some-
times implemented standardized cost-accounting principles to guide providers in costing care 
processes associated with clinical conditions (Busse et al., 2013). Since diagnostic related 
grouping (DRG) reimbursement systems were established in the 1980s, these principles were 
often designed to cost condition-specific care processes in hospitals (Busse et al., 2013). DRG-
based reimbursement was designed to cover a set cost per DRG. Cost estimates were developed 
from aggregating the results of DRG-specific micro-costing studies within hospitals (Busse et 
al., 2013). Activity-Based Costing (ABC) has become the most common approach (Busse et 
al., 2013). ABC adopts a micro-costing approach to cost-accounting that uses carefully selected 
cost drivers to drive resources or resource pools to activities involved in care delivery. How-
ever, as a micro-costing approach, providers found ABC to be resource intensive and difficult 
to update, resulting in inconsistent application of this method (Kaplan and Anderson, 2004, 
Kaplan and Anderson, 2007, Udpa, 1996).  
A landmark publication has claimed that a better solution lies in putting providers at the fore-
front by having them execute a simple-to-apply micro-costing approach that crosses organiza-
tional boundaries, allowing them to cost the entire care pathway of specific chronic conditions 
(Kaplan and Porter, 2011). The approach, called Time-Driven Activity-Based Costing 
(TDABC), brings together micro-costing and integrated care in order to facilitate a solution to 
the cost crisis. 
3.2 TIME-DRIVEN ACTIVITY-BASED COSTING 
TDABC, developed from outside the health care industry, was designed to overcome the limi-
tations of ABC. TDABC is supposed to be less resource intensive and easier to apply because 
it only requires two parameters: 1) The annual cost of resources involved in care delivery, and 
2) The amount of time those resources are available for use each year (Kaplan and Anderson, 
2004, Kaplan and Anderson, 2007). The method was introduced to health care systems as the 
cost component of value within the Value Based Health Care (VBHC) framework, where value 
is defined as health outcomes achieved per unit cost (Kaplan and Porter, 2011, Porter and 
Teisberg, 2006). In order to appropriately capture health care costs, a health care-specific 
seven-step approach to TDABC was developed (Kaplan and Porter, 2011). 
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Step 1: Select the medical condition. 
Step 2: Define the care delivery value chain. 
Step 3: Develop process maps of each activity in patient care delivery. 
Step 4: Obtain time estimates for each process. 
Step 5: Estimate the cost of supplying patient care resources. 
Step 6: Estimate the capacity of each resource, and calculate the capacity cost rate. 
Step 7. Calculate the total cost of patient care. 
Selecting the medical condition is not as simple as identifying a condition by name, but calls 
for a broad and integrated definition: 
An interrelated set of patient circumstances that are best addressed in a coordinated 
way and should be broadly defined to include common complications and comorbidities. 
[… ] For each condition, we define the beginning and end of the patient care cycle. For 
chronic conditions, we choose a care cycle for a period of time, such as a year. (Kaplan 
and Porter, 2011) 
In the second step, the Care Delivery Value Chain (CDVC) is the condition-specific care path-
way, charting all activities involved in the treatment of the selected condition. The capacity of 
a resource is the amount of time the resource is available for care delivery during a year. De-
termining the capacity involves three steps: 
1. Obtain the number of days available for care in a year. 
2. Estimate how many hours the resource is available for care each day. 
3. Estimate how many hours the resource is occupied for non-care related activities each 
day. 
From these estimates the practical capacity is calculated, which is the number of hours the 
resource is available for care each year. With human resources, for example, non-care related 
activities include education, breaks, training, and administrative meetings. The Capacity Cost 
Rate (CCR) is the cost of a resource per unit time, or cost per minute, and is calculated by 
dividing a resource’s annual capacity by its annual cost. In the final step to calculate the total 
cost of care, the CCR for each resource is multiplied by the total amount of time it is used in 
each condition-specific process. The originators of VBHC explicitly emphasized that providers 
should not be held accountable for adherence to CDVC processes, because both provider or-
ganizations and patients are far too unique and care too complex to micromanage (Porter and 
Teisberg, 2006). This is based on strong evidence that under DRG-based reimbursement, pro-
viders reacted with unanticipated behavior changes, resulting in early hospital discharges and 
a lack of accountability for complications and readmissions (Mihailovic et al., 2016). The 
VBHC framework adopts a bundled payment-based reimbursement system, but where provid-
ers are reimbursed for bundled costs across the care cycle from first contact up until follow-up 
for a given medical condition, including co-morbidities and complications (Kaplan and Porter, 
2011, Porter and Teisberg, 2006). These fixed bundled payments are reimbursed for specific 
conditions and facilitate competition among providers to deliver the specified outcomes at the 
lowest cost (Porter and Teisberg, 2006). The siloed nature of the health care system together 
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with a high prevalence of MCC patients presents a challenge to VBHC and the bundled pay-
ment reimbursement system. 
3.3 THE CHALLENGE OF COSTING CARE FOR PATIENTS WITH MULTIPLE 
CHRONIC CONDITIONS IN A REDUCTIONIST HEALTH CARE SYSTEM 
The health care system of the 20th century firmly adopts a reductionist-based care delivery 
approach, providing single treatments for single conditions with a single cause (OECD, 2011). 
Health care systems have a moral responsibility to adapt their approach to match the needs of 
21st century patients, and 50% of the disease burden is caused by MCC patients. Within these 
current reductionist systems, patients experience uncoordinated, redundant, fragmented and 
impromptu care (OECD, 2011, Fortin et al., 2007) that compromises quality and outcomes 
(Wolff et al., 2002). It is widely accepted that a more integrated approach to care delivery is 
required to meet the needs of today’s patients, and the OECD suggested the first step is to break 
with traditional approaches and instead organize care around categories of MCC patients 
(OECD, 2011).   
While VBHC calls for an integrated cross-boundary approach to care delivery, it has struggled 
to overcome these challenges. The fragmented nature of care has obstructed providers from 
adopting costing infrastructures, such as TDABC, that span the entire CDVC in order to inform 
bundled payment systems (Maddox and Epstein, 2018). The VBHC literature does not explain 
how to practically generate CDVCs for MCC patients in order to cost processes. This is because 
the care pathways for MCC patients are incoherent with no discernibly interrelated health care 
patterns or activities (Haggerty, 2012), rendering the pathways impossible to standardize. Inte-
grated care models offer insights into how to conceptualize these pathways. 
3.4 INTEGRATED CARE 
Integrated care serves as the shift from reductionist care to health care delivery with a systems 
approach, and is designed to develop efficiency and coordination throughout the care pathway 
(OECD, 2011, WHO., 2016). Seated as the gate-keepers at the point of contact, general prac-
titioners are strong candidates for managing integrated care models (OECD, 2011, de Bruin et 
al., 2012). The chronic care model originally designed by Edward Wagner (Boehmer et al., 
2018, Coleman et al., 2009) and the medical home model (de Bruin et al., 2012) are the two 
core integrated care models that allow general practitioners to coordinate care delivery for 
chronically ill patients. These integrated care models are generally designed to treat patients 
with a specific chronic condition, but have been used more and more treat MCC patients (Boult 
et al., 2009, Boyd and Fortin, 2010, Versnel et al., 2011). These integrated care models however 
have not been demonstrated to lead to the desired health care improvements, given the limited 





A third health care model, the Integrated Practice Unit (IPU), is introduced within the VBHC 
framework and is defined in the context of secondary and tertiary care centers as: 
organized around the patient and providing the full cycle of care for a medical condi-
tion, including patient education, engagement and follow up and encompass inpatient, 
outpatient and rehabilitative care as well as supporting services. (Porter and Teisberg, 
2006) 
IPUs are not always developed around patients with multiple chronic conditions (van Harten, 
2018). To reinforce the multidisciplinary focus of this thesis, IPUs designed to treat MCC pa-
tients will be referred to as Integrated Multidisciplinary Care (IMD-Care) centers. While evi-
dence is beginning to emerge that IMD-Care centers lead to improved patient experience, 
quality of care, and outcomes (Epstein, 2014, Even et al., 2019, Vare et al., 2016, Weber et al., 









The aim of this thesis is to explore how time-driven activity-based costing can be applied to 
capture and compare the cost of care processes for patients with multiple chronic conditions, 
with specific emphasis on medical specialty-focused versus integrated care models. 
This wider aim is achieved through four individual studies with specific objectives to: 
1) Study I:  explore the existing literature base to unpack and learn from previous 
applications of time-driven activity-based costing in health care.  
2) Study II: explore the initial effects of integrated multidisciplinary care on total care 
utilization patterns of patients with multiple chronic conditions. 
3) Study III: explore how TDABC can be applied to cost care in an integrated 
multidisciplinary care center customized to cost care for patients with multiple chronic 
conditions. 
4) Study IV: apply the new customized time-driven activity-based costing approach to 








5 METHODS  
5.1 PHILOSOPHIC RESEARCH FOUNDATIONS  
Before detailing the methods of the research design and methodology of the thesis, it is im-
portant that the philosophical foundations of this research be explained. As objective and fac-
tual as our culture may perceive scientific research to be, science is a social construction and 
therefore bound by the instability inherent to all social constructions. Several paradigms have 
emerged that characterize the philosophical underpinning of how we understand and approach 
scientific research; a researcher will unavoidably adopt one of these paradigms. Preferred prac-
tice is for researchers to take a position and explain the philosophical foundations of their 
praxis, because this will influence the interpretation and use of the knowledge generated.  
The relevant branches of philosophy through which researchers discuss the philosophy of sci-
entific research are epistemology and a subbranch of metaphysics called ontology. Ontology is 
the study of what exists, and how entities within reality are related and categorized. Epistemol-
ogy is the study of knowledge, i.e. the depiction of what is known, and the processes of justifi-
cation through which knowledge is established (Healy and Perry, 2000). The ways in which 
we look at the world and understand and perceive reality as individuals, or our ontological 
beliefs, has an impact on how we approach scientific inquiry and research – our epistemological 
approach. Most discussions of philosophy of science in research center around two metaphys-
ical ways of understanding reality. The classical view holds that the world exists independently 
of those who observe it, and the objects within the world take the center stage of scientific 
inquiry. The modern view holds that the world and its contents exist inside the consciousness 
of the observer, which becomes the subject of investigation in scientific inquiry (Guba and 
Lincoln, 1994). These two views create a spectrum on which a dizzying set of defined terms 
fall, and it can be difficult to pull the relevant pieces out of the rabbit hole without falling in. 
Researchers often associate positivism, realism, objectivism, and quantitative methodology 
with a classical metaphysical view of reality. Realism is an ontological belief holding that re-
ality exists independent of conscious individuals perceiving that reality, that reality is governed 
by set of fixed rules and laws, and that reality can be studied without interference from the 
mind (Healy and Perry, 2000). Objectivism is an epistemological approach that prioritizes min-
imal interaction with the reality under study, so that subjects under study react to interventions 
as they would if the researchers were not present (Healy and Perry, 2000). Positivism is a phil-
osophical paradigm that adopts a realist and objectivist approach to scientific inquiry, and often 
uses a quantitative methodology. Positivism is historically the dominant paradigm in modern 
scientific philosophy and is often associated with tightly controlled and replicable quantitative 
methods, which allow for reproducible results. The Randomized Controlled Trial (RCT) serves 
as the strongest source of evidence in positivism. Positivism has been criticized for developing 
scientific findings that are not relevant for reality, because the research is performed under such 
sterile conditions that the findings cannot be reproduced in practice. 
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On the modern metaphysical spectrum of how reality is understood, lies interpretivism, social 
constructivism, idealism, relativism, subjectivism, and qualitative methods. Idealism is an on-
tological world view, holding that reality exists within the mind of the observer and is therefore 
unstable and takes multiple forms (Healy and Perry, 2000). Subjectivism is an epistemological 
approach that acknowledges that the subjects of research are influenced by researchers and vice 
versa, and that researchers and subjects affect reality together through the research process. 
Relativism, interpretivism, and constructivism are all philosophical paradigms that adopt an 
idealist and subjectivist approach to scientific inquiry. These paradigms have their differences, 
but they are often associated with explorative qualitative methods, sociological research, and 
anthropology. Interestingly, Auguste Comte, who created the positivist ideology, was also the 
founder of the field of sociology. Interpretivist research is often criticized because the findings 
are either too theoretical to be practically applied, or because they are too context-specific to 
be generalized to other contexts. 
Post-positivism, perhaps the most prevalent currently, is a positivist paradigm that adopts a 
realist ontology but acknowledges the interference of human nature and consciousness in the 
objectivity of the scientific process. Critical realism is a form of post-positivism, and is the 
paradigm adopted for this thesis. From the ontological point of view of a critical realist, there 
may be a single independent reality, but perception of any component of that reality will never 
be complete, because perception and reality are fundamentally separate (Bhaskar, 2013). Fur-
ther, the critical realist separates the study of conscious individuals from that of the physical 
world they experience. This worldview allows for objectivism and subjectivism to be integrated 
in the practice of research. Critical realism thus gives us a philosophy to be applied in real-
world practice within human institutions (Bhaskar, 2013), and thus a philosophy upon which 
we can act, making it ideal for this PhD thesis. 
5.2 SETTING 
This research was performed in real-world practice within a human institution. Studies II to IV 
were conducted within the context of an IMD-Care center for patients who concomitantly ex-
perience heart disease, kidney disease, and diabetes (Spaak, 2015, Porter and Lee, 2013). The 
clinic is often referred to as the HND Center, where “HND” stands for Heart, Nephrology, and 
Diabetes. The HND Center was established in November of 2013 at a university affiliated ter-
tiary teaching hospital in Stockholm, Sweden. The hospital, one of the largest emergency hos-
pitals in Sweden, offers education and conducts research activities in many clinical specialty 
areas, and is one of the three teaching hospitals associated with Karolinska Institutet. The hos-
pital has around 4,000 employees and treated 90,000 emergency patients in 2018.  
The goal of the HND Center was to provide integrated multidisciplinary patient-centered care 




Figure 1: Workflow summary of the HND Center 
 
visits, and acute unplanned hospital visits. The approach to achieve these reductions was to 
optimize care for HND patients by eliminating unnecessary care, improving the quality of care, 
and lowering the cost of treatment. 
The HND Center is the showcase interdisciplinary care center at a Swedish hospital and is run 
by a consultant cardiologist. The Center is an outpatient clinic and operates during normal 
working hours. The care team includes doctors from the involved specialties, nurses, and un-
dersköterska (USKs). USKs are similar to the positions of licensed practical nurses in the 
United States, or Health Care Assistants in the United Kingdom.  The team is supported by 
physiotherapists, dietitians, part-time nurses who specialize in relevant care, and six physicians 
on a rotating schedule. The physicians include two specialists from each of the three disciplines.  
The HND care team adopts a person-centered care approach, delivers outpatient care at the 
HND Center, and coordinates the remainder of care delivered to HND patients outside the 




follows a patient-centered care design and coordinates all care delivery from a single location. 
The care process, shown in Figure 1, begins with a new visit to get acquainted with the patient 
and their circumstances. This is followed by a team conference with the clinical team – includ-
ing specialists in cardiology, nephrology, and endocrinology – to discuss the patient’s circum-
stances and draft a health plan. This health plan is discussed and formulated together with the 
patient during the following team visit. The plan is executed utilizing an iterative and adaptable 
series of follow-ups and evaluations, both in person and over the phone. The nurses have the 
necessary knowledge to allow delegation for them to adjust medications, titrate heart failure 
medications, and follow up life-style interventions to a large extent over the phone. 
5.3 THE HND RANDOMIZED CONTROLLED TRIAL: CAREHND 
This thesis draws from an ongoing RCT (RCT; CareHND). The RCT was designed to investi-
gate the impact of the HND Center on costs and outcomes. Patients were recruited to the RCT 
and randomized to receive either traditional or HND Center care if they met the following 
clinical criteria specified by a multidisciplinary team of clinical consultants (Spaak, 2015): 
1. Established cardiovascular disease, indicated by a history of 
hospitalization following angina, acute coronary syndrome, or heart 
failure. 
2. Diagnosis of diabetes mellitus type 1 or 2. 
3. Established kidney disease, defined as an estimated glomerular filtration 
rate level less than 60 mL/min/m2, or borderline glomerular filtration rate 
levels and macroalbuminuria.  
5.4 OVERVIEW OF THE STUDIES 
This thesis is comprised of the four studies outlined in Table 1. Study I was a systematic liter-
ature review used to establish a firm understanding of the TDABC costing methodology and 
how it has been applied in the health care context. Using the randomization of the RCT, Study 
II characterized the care experience of HND patients and provided an initial care utilization 
comparison of HND and traditional care processes. Study III drew from the findings of Studies 
I and II to explore how to apply TDABC to cost care for HND patients, and Study IV used the 





Table 1: Overview of the studies 
 
 I II* III* IV* 
Aim To explore why 
TDABC has been  
applied in health care, 
how its application 
 reflects a seven-step 
method developed 
specifically for VBHC, 
and implications for 
the future use of 
TDABC 
To explore the initial 
effects of integrated 
multidisciplinary care 
on total care utilization 
patterns of patients 
with multiple chronic 
conditions 
To explore how 
TDABC can be  
applied to cost care 
in an integrated 
multidisciplinary 
care center  
customized to cost 
care for patients 
with multiple chronic 
conditions 
To apply the new 
 customized time-driven 
activity-based costing 
approach to evaluate 
an integrated  
multidisciplinary care 
center in comparison to 
traditional care models 
Research de-
sign 
A systematic review 
following the PRISMA 
statement 
Statistical comparison 








Systematic search of 
eight databases,  
exclusion of articles 
according to  
pre-defined criteria 
Data were collected 
from Stockholm Re-
gion’s administrative 
health care database, 






pital admin. data + 
electronic health 
records 
Triangulation of multiple 
data sources:  
contextual  
observations, + hospital 
admin. data +  
electronic health  
records 
Data-analysis Qualitative content 
analysis to compare 
applications and  
describe the 
 adherence to a 
 theoretical model 
(TDABC seven steps) 
Wilcox Ranked Sum 
tests for comparison 
of care utilization  
variables 
Guided by the 
seven-step  
approach to TDABC 
applications in 
health care 
According to the modi-
fied seven-step ap-
proach to TDABC 
applications developed 
in study III 
*Based on the ongoing CareHND RCT 
 
5.5 STUDY I 
5.5.1 Study design 
The first study was a systematic review of the literature designed to assess why TDABC has 
been applied in health care organizations, the degree to which these applications reflect the 
seven-step approach developed specifically for VBHC, and what lessons can be taken for future 
applications of TDABC in health care. Literature search and selection was guided by the Pre-
ferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement 
(Moher et al., 2009), and selected articles were analyzed using qualitative content analysis 
(Graneheim and Lundman, 2004, Hsieh and Shannon, 2005). 
5.5.2 Data collection 
The data collected for analysis in this study was the content of the articles identified within the 
review. A search strategy was developed for each of seven major databases, where all word 
formulations of the phrase “Time-Driven Activity-Based Costing” were included. The seven 
databases, and the corresponding search strategies used are presented in Appendix 1. Articles 
were reviewed that met a set of inclusion criteria. First, articles were identified that included 
some formulation of the phrase “TDABC” in the title or abstract. Second, abstracts were 
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screened, and papers were only included if the topic was specific to the health care field. Fi-
nally, following full text reads of the remaining articles, articles were selected for analysis if 
they discussed or described an empirical application of TDABC in practice. A PRISMA flow 
diagram is provided in Figure 2. 
5.5.3 Data analysis 
The general study characteristics of selected articles were extracted, including publication year, 
the country in which the study was performed, the medical specialty involved in the cost anal-
ysis, and the type of health care organization in which the study was performed.  
Each article was then analyzed through two phases of content analysis (Graneheim and 
Lundman, 2004, Hsieh and Shannon, 2005), both performed using NVivo qualitative data anal-
ysis software; QSR International Pty Ltd. Version 10, 2012. First, an inductive analysis was 
performed on data identified and extracted from the articles that described strengths, weak-
nesses, and the rationales for choosing to use TDABC for their analysis. The content was 
grouped to identify common specific themes and insights about how TDABC should or should 
not be applied. The second phase of the content analysis was deductive and aimed to describe 
how well each application adhered to the seven-step health-care-specific approach to TDABC. 
An analysis template was constructed in NVivo where article content relating to each step could 
be identified and linked to each of the seven steps.  
5.6 STUDY II 
5.6.1 Study design 
This was a quantitative study of an ongoing RCT that compared the initial effects of an IMD-
Care center on care-utilization patterns of MCC patients, specifically HND patients.  
5.6.2 Data collection 
Data were obtained from the VAL database, a Stockholm Regional database that collects elec-
tronic health records (EHR) and other administrative data from provider organizations through-
out the region. At the time of this study, 110 patients had been recruited to the RCT. Data were 
collected for these 110 HND patients from January 2008 to April 2018, including demographic, 
diagnostic, and care-utilization data. Care-utilization data included the occurrence of inpatient, 
outpatient, primary care, planned, and unplanned visits, as well as the length of stay for each 
inpatient visit. 
5.6.3 Data analysis 
Wilcoxon Ranked Sum Tests were used to compare a set of care-utilization frequency-of-event 
variables, including inpatient visits, Emergency Department (ED) visits, and primary care visits 
among others. A non-parametric test was required because frequency data often take on a Pois-
son distribution shape, which is heavily skewed right, violating the assumption of normality.  
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Given that patients were recruited slowly over time, their care utilization patterns needed to be 
normalized around time zero of the intervention. Therefore, all event time parameters were 
adjusted to represent the time elapsed between exposure to the treatment arm, and the occur-
rence of the event. Further, many of these patients were recently recruited up to a few months 
before the time of this analysis. Therefore, there was a limited availability of prospective data 
from some patients, and a 6-month cut-off time period was used. All patients providing less 
than six months of data were excluded from the analysis. This cut-off included a mortality 
adjustment, where patients who died before providing six months of data were also excluded. 
After these adjustments, 77 of the 110 patients remained for analysis: 35 in the control arm and 
42 in the intervention arm. 
Charlson Comorbidity Index (CCI) (Charlson et al., 2008, Charlson et al., 1987) scores were 
calculated using International Classification of Diseases codes from the diagnostic data. These 
scores were used to acknowledge the level of morbidity within each RCT arm when performing 
the statistical comparisons. 
5.7 STUDY III 
5.7.1 Study design 
This study was a cost analysis that explored how TDABC can be applied to cost care for MCC 
patients, specifically HND patients. Multiple methods were used for both data collection and 
analysis, which were guided by a version of the health care-specific seven-step approach to 
TDABC modified specifically for MCC patients. 
5.7.2 Data collection and analysis 
5.7.2.1 Select the medical condition (Step 1) 
HND patients were defined according to the inclusion criteria for the RCT previously described 
in section 5.3. Patient recruitment to the HND Center is ongoing and began in early 2014. In 
order to allow the processes at the HND Center to stabilize, the first few hundred patients who 
received HND care were not included in the RCT. Recruitment to the RCT began after Health 
Care Professionals (HCP) became comfortable with routines and felt that HND Center pro-
cesses were stable. For this study, data was collected for the 314 HND patients that had been 
receiving HND care by the end of the 2017 year. Most of these patients were not recruited to 
the RCT, but HND processes had long since stabilized and those patients not recruited to the 
RCT had been using HND services for a few years. 
5.7.2.2 Define the CDVC (modified step 2) 
This is where the major modification of the seven-step approach needed to be made to fit the 
specifics of the HND context. According to the seven-step approach, CDVCs are to be estab-
lished for the entire cycle of care (Kaplan and Porter, 2011). For patients with chronic condi-
tions, where the condition is continuous, a time-period of one year should be set (Kaplan and 
Porter, 2011). MCC patients, however, experience highly variable care processes. For HND 
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patients, no standardized care processes have been defined. In fact, there is such a degree of 
variation that it becomes extremely difficult to identify or visualize patterns. Therefore, it is 
currently not possible to define a year-long CDVC to treat these patients. Instead, we identified 
those activities that were performed over one year and averaged their frequencies, disregarding 
their sequence. 
The CDVC was defined as all activities performed over a single year of care but was limited 
to those activities performed at the HND Center. The CDVC was depicted using the annual 
average frequencies of HND care delivery activities. Activity frequencies were obtained from 
two separate systems for comparison and validation purposes, from the medical records and 
from the scheduling system. Both data sets were cleaned in R Statistical software (R Core 
Team, 2019) and analyzed to produce annual frequencies of all activities performed at the HND 
Center. 
5.7.2.3 Develop process maps and estimate the time of activities (steps 3 and 4) 
Process maps were generated over a series of development and validation steps together with 
researchers and staff. First, staff presented HND process maps as they existed within hospital 
systems. Based on the findings from the literature review, these maps were deemed unusable 
for TDABC purposes, and new maps were to be developed from scratch. Observational data 
were collected over a series of 10 days by three researchers using hand-held electronic data 
collection programs on smartphones. Each observed event was populated with a list of param-
eters including the activity type, location, and the duration of HCP’s involvement in each ac-
tivity. Data were uploaded to a cloud database and analyzed in R Statistical Software (R Core 
Team, 2019) to generate process maps in tabular form. These tabular maps were transferred 
onto flip chart paper and Post-it® notes and presented to HND HCPs in stages. HCPs were first 
shown the activities involved in a process map and were asked to add or remove activities so 
that the maps would more accurately reflect their care delivery routines. They were then asked 
to estimate the duration of the time they spent on each step in the process. Afterwards, time 
estimates developed from observational data were revealed. The differences were discussed, 
and a final process map was agreed upon. This was repeated for each type of activity performed 
at the HND Center. 
5.7.2.4 Estimate the cost of resources (step 5) 
Resource costs were estimated from two managerial accounting Microsoft Excel (Office 365) 
workbooks provided by hospital controllers. The first workbook provided accounting and ca-
pacity data for HCPs working at the HND Center, which included sick leave, bonuses, vacation 
pay, overtime, and education-based pay. Social insurance costs were applied according to Swe-
dish standards at a rate of 47% of base salary. The second workbook provided costs generated 
in the hospital’s chart of accounts by HND patients. Costs included in the chart of accounts 
beyond HCP costs were facilities space, lab, radiology, and pharmaceuticals. 
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Pharmaceutical and facilities space costs were calculated by developing a standard outpatient 
fixed cost per visit for the entire Cardiology clinic and driven to each care delivery center (in-
cluding the HND Center) according to the number of outpatient visits performed at that center. 
Radiology and lab costs were charged directly to the HND care center when ordered.  
For this analysis, HCP resources were driven to activities using the amount of time they spent 
within each activity. Pharmaceutical, lab, and radiology costs were distributed among physi-
cian and team visits, because they are prescribed and ordered by physicians. Facilities space 
were allocated to visits on a per-square-meter-per-minute basis. 
5.7.2.5 Estimate the capacity and capacity cost rates of resources (step 6) 
The first workbook provided by hospital staff also included capacity data for all HCPs working 
at the HND Center. The capacity data was provided as the number of Full-Time Equivalents 
(FTEs) of each HCP type working during a single year at the HND Center. The workbook 
included all theoretical capacity figures, including care delivery hours, sick leave, paid leave, 
parental leave, and teaching work. These figures, with the exception of care-delivery time, were 
aggregated for all HCP types, and therefore a single practical capacity adjustment figure was 
used to adjust down all FTEs to estimate the time used simply for care delivery. Further, ca-
pacity data were not provided for physicians, but HND HCPs made it clear that one physician 
FTE was present each day of operation of the HND Center.  
Given the capacity-related challenges identified in the first workbook, researchers together with 
HCPs decided to manually process the calendar data for the 2018 year to obtain another capac-
ity estimate for validation and comparison purposes with the workbook. Each day of the cal-
endar was reviewed for the HND Center in the 2018 year, and the number of hours of each 
HCP type was manually counted. This data could not be extracted and processed using com-
puter software, as hospital systems did not allow for this functionality. Therefore, data were 
manually entered into a Microsoft Excel (Office 365) file for processing. 
After obtaining capacity estimates for each HCP type, the annual costs obtained in step five 
were used to estimate the cost per minute, or the CCR, for each resource. 
5.7.2.6 Estimate the total cost of care (step 7) 
The final step of this analysis was to calculate the total cost of HND care. The CCRs for each 
resource were multiplied by their corresponding duration-estimates for each activity performed 
at the HND Center. Other costs were driven to activities as described in Step 5, and the total 
cost of each activity was estimated. These costs were multiplied by the annual activity frequen-
cies presented in the CDVC, and the sum of the total annual costs of each activity was used as 




5.8 STUDY IV 
5.8.1 Study design 
The fourth study of this thesis was also a TDABC cost analysis using multiple methods to 
collect and analyze real world data and aimed to compare the costs and select care utilization 
outcomes of HND and traditional care processes for HND patients. The comparison used the 
randomization from the HND RCT, and thus the inclusion criteria were the same. Patients 
could choose to cross over from one arm to the other arm one year after being included in the 
RCT. The cost comparison was performed within the 2018 fiscal year, and patients included in 
this study were those that had been randomized within the RCT during or before 2018, which 
included 54 patients in the traditional care arm and 65 in the HND care arm.  
5.8.2 Data collection and analysis 
5.8.2.1 TDABC costing 
The data pulled from the RCT included the patient’s ID number, the arm to which each patient 
was randomized, the date of inclusion in the study, and if they patient had died, the date of 
death. Beyond the patient information, data was collected to complete the modified seven-step 
TDABC cost analysis of traditional and HND care processes in 2018. Data were also collected 
on key care utilization variables including emergency room visits, inpatient visits, hospital 
days, and primary care visits. 
For the first step of the seven-step approach, the condition was defined according to the inclu-
sion criteria for patients recruited to the HND RCT.  
In Study III of this thesis, the CDVCs of HND care processes were collected from the HND 
Center’s calendar system. This was appropriate because Study III included all patients who had 
been exposed to HND care. Study IV only analyzed patients randomized to the RCT, and there-
fore the scheduling system was not appropriate as it could not be filtered to include only ran-
domized patients. Therefore, the patient journals were accessed to collect CDVC data. Patient 
journal data could be viewed digitally in tabular form but could not be downloaded or copied 
into a data table. Therefore, the author together with Gudrun Even, a fellow doctoral student, 
manually counted clinical event data for each randomized patient for the entire 2018 year. The 
activity data recorded for each clinical event included the type of visit, the patient’s ID, the 
visit date, and the visit location. Data for each patient included the patient’s ID, mortality data, 
date of inclusion in the RCT, date of ability to crossover, and the decision to crossover.  
As the CDVC data was collected, key care utilization variables outside the defined CDVC were 
also counted. The number of primary care visits, inpatient visits, inpatient days, and emergency 
room visits were also recorded for each patient. The patient ID and date associated with each 
visit was recorded.  
Through discussions with HND health care professionals, it was known that the first year of 
HND care could be care intensive in order to stabilize care processes for HND patients newly 
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recruited to the (R Core Team, 2019)center. Therefore, a set of six CDVCs were defined: first 
year HND patients, first year traditional care patients, second year HND patients, second year 
traditional care patients, HND patients that crossed over to traditional care, and traditional care 
patients that crossed over to HND care.  
Process data were collected according to the same approach established in the second study. 
However, because processes were to be observed outside the HND Center in the kidney and 
cardiology outpatient wards, it was important that they were performed by a hospital employee. 
Gudrun Even was not only a fellow doctoral student in the HND initiative but also a nurse at 
the hospital. She collected all observational data used to construct process maps for each visit 
occurring in the different CDVCs. As in the second study, she used a hand-held mobile data 
collection device to collect data and upload it to a secure data cloud. She recorded 163 obser-
vations at the HND Center, 284 observations at the nephrology ward, and 250 at the cardiology 
ward. These data were used to construct process maps which, as in Study III, were validated 
with HND HCPs.  
Hospital controllers provided financial data for the HND Center, the nephrology outpatient 
center, and the cardiology outpatient center. The same procedures used to analyze costs at the 
HND Center in Study III, in 2018, were applied at each individual center in 2018. The same 
Excel Workbooks provided in 2017 for the HND Center were provided for each of the three 
settings for the 2018 year. Capacity and cost data again included sick leave, bonuses, vacation 
pay, overtime, and education-based pay. Social insurance cost was again applied at a rate of 
47% of base salary. Non-staff costs including facilities, pharmaceuticals, radiology, and lab 
costs were all applied to clinical activities using appropriate cost drivers.  
One key difference in this study as compared to Study III, was that HND patients only com-
prised of a fraction of the care delivered at each setting. Many of the patients treated at the 
cardiology center and the nephrology center were not HND patients. Even at the HND Center, 
many of the patients treated were not recruited to the RCT. Therefore, non-staff cost resource 
pools could not be driven according to manually counted visit frequencies within the CDVCs. 
To estimate appropriate cost drivers, the Qlikview EHR data was used to obtain rough estimates 
of all visit frequencies in each of the three locations. The proportion of visits counted within 
the CDVCs for randomized patients in each of the three settings, as compared to the total num-
ber of visits that occurred in each of the three settings, was used to drive non-staff costs to 
activities. 
HCP FTE estimates at each of the three settings were again obtained by Microsoft Excel (Office 
365) workbooks provided by controllers. Practical capacity estimates were made, again after 
accounting for sick leave, paid leave, parental leave, and teaching work. Capacity estimates for 
HCPs were again manually obtained from the calendar data in each setting. Gudrun Even was 
granted access to the scheduling systems in each of the three settings. To estimate the capacity 
cost rates for each HCP type in each setting, their respective annual costs were divided by their 
annual capacities.  
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In the final step of the costing analysis, all non-staff costs were driven to activities and the HCP 
CCRs were applied to their respective working durations in each activity. The frequency of 
each activity in each CDVC was multiplied by its corresponding cost to estimate the total cost 
of each CDVC for the 2018 year. 
5.8.2.2 The cost comparison of HND and traditional care 
Statistical analyses were performed to compare the cost of HND Center care processes to those 
of traditional care. First the TDABC total cost estimate of each CDVC was divided by the total 
number of days patients were exposed to each CDVC, in order to estimate the cost of care per 
patient-day of exposure. These figures were extrapolated out to a year to estimate the cost per 
year of treatment for a specific CDVC.  
General linear models (GLM) were used to compare care utilization variables between HND 
and traditional care. Event based data is skewed right, occasionally without equal variance, and 
occasionally zero-inflated. An appropriate GLM was identified for each care utilization varia-
ble: ED visits, inpatient visits, hospital days, and primary care visits. If a dataset had equal 
variance and no zero inflation, a Poisson regression model was used for the comparison. If 
there was no-equal variance and no zero inflation, a negative binomial model was used. Finally, 
in the case of unequal variance and zero inflation, a hurdle model was used for the comparison. 
The four GLMs were used to test for statistically significant differences in the mean frequencies 
of care utilization variables occurring per year during exposure to different CDVCs. This was 
done through exponentiating the model coefficients to obtain the odds ratios specific to each 
care utilization variable.   
Cost estimates were obtained for Region Stockholm for a single occurrence of each of the four 
care utilization variables. Statistically significant differences in annual care utilization frequen-
cies were converted to monetary cost differences. The annual cost of care obtained from the 
TDABC analysis was combined with the added cost of each of the care utilization variables for 
each of the CDVCs. The comparison of these total costs represented to cost differences between 
each CDVC, including the cost of the four selected care utilization variables.   
5.9 ETHICAL CONSIDERATIONS 
Both the Personal Data Act and the Ethical Review Act apply to this research project because 
data involving human subjects is collected. Clear guidelines and an ethical review process are 
available to ensure that issues of informed consent and personal data protection are considered 
and handled appropriately.  
This research was careful to maintain ethical rigor throughout the research process, and care-
fully adhered to established ethical guidelines, principles, and standards. All studies within this 
thesis were approved by the Regional Ethical Review Board in Stockholm, Sweden through 




All patients included in the HND RCT provided consent for this research, and all patients were 
given the opportunity to withdraw from the research at any point. The written informed consent 
document is stored within the patient’s medical record at the hospital. In the event of a data 
withdraw, all data specific to that particular patient would have been removed. No patient re-
quested to be withdrawn from the study. All patient data was collected by hand (never emailed, 
faxed, or mailed) and was coded using conditional random fields (CRF). All data collected 
from the hospital was done so following the establishment of a signed data-sharing contract 
between the hospital and the research institution. All personal sensitive data extracted from the 
hospital was encrypted and stored on secure servers at the research institution. The CRF model 
remains on site, and data was brought to the CRF for compilation and processing when neces-
sary. 
The demonstration of objective and appropriate handling of informed consent and sensitive 
information is easily documented using established and accepted practices. However, for some 
other ethical considerations, reflection on and demonstration of the correct course of action 
becomes less objectively clear. It is also important to consider other ethical implications that 
are not as clear as ethical recommendations and guidelines. This research is grounded in an 
empirical real-world setting, which surfaces two ethical issues.  
First, the collection of financial and human resource data is sensitive information for the or-
ganization and its employees. The hospital was open to sharing such information with the re-
search group because the project was collaborative, and part of our objective was to support 
the hospital in understanding the cost of HND patient care processes. The physician employed 
by the hospital who leads the HND initiative is a member of the research group, and, through 
him, the group established a strong relationship of trust with the organization. All submitted 
manuscripts were reviewed by hospital staff prior to submission, and hospital staff were closely 
involved in each step of the research process. Routine contact was maintained with clinical 
staff on the floor, economic staff in the administrative department, and managerial staff at the 
hospital. Consensus among the research group was established around all information sharing 
decisions.  
Second, the results of this project may influence the decisions of providers and managers at the 
hospital, and possibly other hospitals. Therefore, it is crucial that data collection, analysis, and 
reporting are conducted with care and attention to detail, using established methods, and are 
presented in a fair and objective way that acknowledges limitations. Further, it is important that 
we as researchers remind management, and other decision makers, that our findings should be 
presented and inferred cautiously and objectively. Specifically, that costs are not the only com-
ponent of decisions around care delivery, and estimations may change over time and between 
contexts. The cost implications emerging from this study must be considered in combination 






6.1 STUDY I 
6.1.1 Study selection 
After running the search strategies of the seven major databases (Appendix 1), 780 records 
were identified for review (Figure 2). After removing duplicates and excluding records and 
articles, 25 articles were selected for analysis that described applications of TDABC in practice. 
The content of these 25 articles served as the data for analysis in this review. 
 
 
Figure 2: PRISMA flow diagram of the systematic literature review 
 
An increasing number of studies were conducted over time, and 80% of the articles were con-
ducted after 2013. The majority (88%) of these studies were performed in a hospital setting, 
and 68% were performed in a surgical setting. The remaining studies costing patient care were 
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6.1.2 Why TDABC was applied in health care 
The articles identified in the review chose to apply TDABC because of its potential contribu-
tions to operational improvement and reimbursement policy. More specifically, articles fol-
lowed claims in the existing literature base that TDABC was simple to apply, capable of 
efficiently and accurately capturing the cost of care processes, and managing the complexity 
of those processes. Many of these claims came from industries outside of health care. This was 
particularly appealing given the surge of interest in VBHC, which brought to the fore the im-
portance of costing care pathways and processes at the level of the medical condition. A Har-
vard Business Review article touted the method as ideal for the VBHC framework less than a 
year before a surge in TDABC health care publications, and 56% of the articles reported the 
strength of the method associated with the VBHC agenda. 
6.1.3 Reported strengths and limitations of TDABC 
Articles in the review sometimes reported that TDABC was simple to apply and allowed for 
self-explanatory cost assignment to care delivery activities through the use of the CCR and 
time estimates. The method was reported, in 10 of the 25 cases, as a highly accurate approach 
to costing, which is most-likely attributable to TDABC being a form of micro-costing. Micro-
costing is a historically accurate, but work-intensive, approach to costing processes. Almost 
fifty percent of articles reported that TDABC allowed for better informed quality improvement 
initiatives, including reduction in wait times, waste, and redundant staff. While no article re-
ported cases where TDABC influenced reimbursement schemes, some papers alluded to the 
method’s potential in this regard. 
6.1.4 Observing the applications of TDABC through the lens of the seven-
step framework 
Interestingly, none of the 25 applications reported a tight adherence to the seven-step health-
care-specific approach to TDABC. However, all applications reflected the seven-step approach 
in some way. 
With respect to the first step – selecting the medical condition – a medical condition is defined 
as an “interrelated set of patient circumstances that are best addressed in a coordinated way and 
should be broadly defined to include common complications and comorbidities” (Kaplan and 
Porter, 2011). All but three articles selected care processes that were specific to a medical con-
dition or set of medical conditions. Of these condition-related TDABC applications, all were 
of single procedures or outpatient visits. No article included comorbidities, adverse events or 
complications, and no article performed an analysis of an entire care pathway or costed care 
beyond the walls of a single department or clinic. 
Defining the CDVC was the most poorly performed of the seven steps in the applications iden-
tified in the review. Only two articles charted activities outside of a single process within the 
patients’ care pathway. These two articles costed the highly standardized care pathways for hip 
and knee surgery. The remaining twenty condition-specific articles only costed the process of 
 
 31 
a single clinical activity. This step must be performed if part of the objective is to inform bun-
dled payment reimbursement. One article did estimate the cost of a bundle for hip and knee 
replacements.  
All articles except for one mapped at least one care process and time estimates of process steps. 
Of these, 71% of articles used contextual observations to collect process mapping and time 
estimate data. Forty-six percent used interviews together with contextual observations. Six 
studies used team meetings or workshops, and three studies used all three methods to collect 
process data. Interviews or round-table discussions were sometimes used to validate observa-
tional data, and observational data was preferred for longer and more complex activities. In one 
case, process maps pulled data directly from the hospital’s EHR. The process of collecting data 
for mapping processes and collecting time estimates was reported to be the most time-consum-
ing and difficult step in the application of TDABC, however this was only reported by articles 
performing contextual observations – four of which reported using only contextual observa-
tions. Six articles reported a high likelihood of inaccuracies in the process data collected, which 
included data entry, reporting errors, difficulties with rare event capture, and the Hawthorne 
effect. 
Most articles in the review reported the collection of personnel costs, and some reported phy-
sician costs as difficult to estimate. No article comprehensively developed CCRs for and cap-
tured all direct costs. Support center costs are those costs incurred by activities and resources 
that are not directly involved in patient care, like economy and laundry. Several articles did not 
include indirect or support center costs, and when included these costs were allocated using a 
range of approaches. Some articles applied support costs as a fixed percentage of direct costs. 
Otherwise, indirect and support center costs were generally allocated using a cost driver like 
square footage or bed days. 
While capacity data collection and analysis were reported in all articles, practical capacity ad-
justments were applied occasionally and in several different ways. Occasionally practical ca-
pacity adjustments were not necessary given the scope and nature of the cost analysis. 
However, if these analyses had been more thorough and comprehensive, practical capacity ad-
justments would have been required. In a few cases, practical capacity adjustments were not 
made when they were in fact necessary. When included, practical capacity adjustments were 
more often applied at a flat rate percentage of theoretical capacity. 
All articles that estimated the cost of resources also calculated CCRs. Of these, all but two 
calculated the CCRs of individual resources. The remaining two calculated the CCR for entire 
processes or for resource pools. One study applied a single CCR for all support center costs 
and applied them at a per-minute basis to all activities. 
All but two articles estimated the total cost of a care process or set of care processes. One article 




6.2 STUDY II 
6.2.1 Characterization of HND patients and their care 
HND patients were mostly over 65 years old and the majority were male Table 2. Patients 
typically had over a dozen diagnoses and generally high CCI scores. The minimum number of 
diagnoses an HND patient experienced was 5, while the maximum was 44. Despite randomi-
zation, HND patients in the intervention arm generally had more diagnoses and significantly 
higher CCI scores. HND patients are high consumers of care, regularly experiencing ten health 
care encounters each month, both during the years before and the months after the intervention 
Table 3. During the six months following the randomization, there was no detectable difference 
in care utilization between the two groups. There was a significant increase in telephone con-
sults in the intervention arm, otherwise care utilization remained the same. 
 




Control Arm  
(traditional) 
Intervention Arm  
(HND) 
Number of participants 
 
35 42 
Gender Female 11 (31.4%) 7 (16.7%) 
 
Male 24 (68.6%) 35 (83.3%) 
Age years mean (Median) 
 
76.26 (75) 74.2 (75) 
Participants based on age subgroups (%) 50–59 0 (0 %) 1 (2.38%) 
 
60–69 7 (20%) 9 (21.4%) 
 
70–79 16 (45.7%) 20 (47.6%) 
 
80–89 12 (34.3%) 12 (29%) 
Median diagnoses per patient (Range) 
 
14.0 (5–44) 17.0 (5–38) 
CCI Score 
   
 
Median 4.0 5.5 
 





Table 3: Comparison of care utilization variables for 24 months pre- and 6 months post   
randomization 
Variable Name Pre-Intervention All (−24 to 0 
Months) 
 Post Randomization (+1 to +6 
Months) Intervention Arm 
 Post Randomization (+1 to +6 
Months) Control Arm 
P-
value 
 Median Mean Range SD  Median Mean Range SD  Median Mean Range SD  
Unplanned visits (per patient per month) 
Total (ED + Inpatient) 2.0 1.9 0.0–5.6 1.0  1.0 1.1 0.0–4.6 1.1  1.0 1.3 0.0–7.0 1.5 0.36 
ED visits 1.2 1.3 0.0–5.3 0.7  1.0 0.8 0.0–4.6 1.0  1.0 0.8 0.0–4.0 0.9 0.32 
Inpatient visits 1.0 0.9 0.0–3.0 0.6  0.0 0.4 0.0–1.5 0.5  0.0 0.5 0.0–3.0 0.7 0.23 
Inpatient visits (per 
patient per month) 
1.0 1.0 0.0–3.0 0.7  0.0 0.3 0.0–1.5 0.5  0.0 0.3 0.0–2.5 0.5 0.69 
LOS per admission 
per patient 
4.0 4.9 0.5–28.0 4.7  3.5 6.0 0.5–34.0 8.6  4.0 4.8 0.0–13.0 3.7 0.34 
Planned outpatient visits (per patient per month) 
Non-telephone all 2.8 3.4 1.4–9.6 1.9  3.4 4.2 1.3–17.2 2.9  3.2 4.8 1.4–17 3.6 0.51 
Telephone 1.0 1.0 0.0–2.1 0.4  1.2 1.3 0.0–2.6 0.6  1.0 0.9 0.0–2.0 0.5 0.00* 
Primary care 1.0 1.2 0.0–12.0 2.1  0.0 0.5 0.0–9.3 1.6  0.0 0.5 0.0–8.0 1.5 0.43 
Nurse 2.0 2.6 1.0 −7.3 1.6  2.1 2.6 1.2–7.3 1.4  1.7 2.6 1.0–7.3 1.7 0.10 
Physician 0.0 0.4 0.0–3.6 0.7  0.0 0.3 0.0–3.6 0.6  0.0 0.4 0.0–1.6 0.6 0.17 
 
6.3 STUDY III 
6.3.1 Results of the TDABC application 
During the 2017 year, 314 patients (286 men and 66 women) averaging 80 years of age received 
care at the HND Center. A set of seven activities were delivered at the HND Center:   
• New Visit 
• Nurse telephone consultation 
• Nurse Visit 
• Physician Telephone consultation 
• Physician Visit 
• Team Conference 
• Team Visit 
During both new visits and team visits, the patient saw both a nurse and a physician, albeit 
separately in the former and together in the later. Doctors, nurses, and USKs met together with-
out the patient during team conferences.   
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The EHR data provided significantly less data when compared to the manually extracted cal-
endar data. After discussing this discrepancy with HND HCPs, it was clear that the EHR data 
was decidedly incomplete. This was confirmed by hospital administrative staff who explained 
that the EHR data was pre-processed in order to comply with municipality reporting standards 
and policies and thus was likely incomplete for operational purposes. The visit frequencies 
obtained from the calendar data were used in the TDABC analysis and are shown in Table 6. 
Detailed process maps with time estimates are presented in tabular form in Appendix 3, and an 
example process map is presented in Figure 3. 
 
Figure 3: An HCP-validated process map for a new visit at the HND Center. 
 
Each process step is labeled with the HCP types involved and their corresponding duration of involvement in minutes. 
 
Each human resource is listed in Table 4 together with the corresponding annual capacities 
(FTEs), costs, and calculated CCRs (costs are always rounded to the Euro). The remaining 
costs are provided in Table 5 with their respective cost drivers. The resulting cost per processes, 
and their annual frequencies are summed together to calculate the total 2017 HND cost of care 












































Table 4: Human resource capacity estimates and CCRs 





[A x B x 12] 
Annual clini-








sent at the 
HND Center 
F. 









[(G ÷ 5) - 1] 
work day 
hrs minus 1 
hr break 
I. 
[F x H] 
Care deliv-
ery hrs per 
year 
J. 
[(C ÷ I) ÷ 60] 
CCR  
(€/ min) 
Physician 5,550.00 1 66,600.00 1.0 202.5 202.5 50 7 1,417.5 0.78 
Nurse 3,022.00 2.79 101,359.00 1.76 231 406.6 37 6.4 2,594.7 0.65 
USK 2,913.63 0.15 5,381.00 0.116 231 26.9 38.25 6.7 178.6 0.50 
 
Table 5: Non-human resource costs and corresponding drivers 
Resource Source Cost  (€/mo) Driver 
Facility costs HND Center chart of accounts 4,923.00 minutes per square meter 
Social welfare Staffing sheets 7,979.00 Personnel 
Clinical chemistry HND Center chart of accounts 3,112.00 Physician visits 
Pharmacy HND Center chart of accounts 3,851.00 Visits 
Radiology HND Center chart of accounts 1,440.00 In-person visits 
Other lab costs HND Center chart of accounts 1,033.00 Visits 
 
Table 6: Annual activity frequency, marginal cost, and total annual cost 
Activity Annual Count Cost** (€) Annual Cost* (€) 
New visit 143 367.00 52,528.00 
Nurse telephone consultation 1545 51.00 78,286.00 
Nurse visit 278 211.00 5,854.00 
Physician telephone consultation 159 60.00 9,469.00 
Physician visit 151 297.00 44,780.00 
Team conference 240 115.00 27,470.00 
Team visit 478 369.00 176,567.00 
Uncaptured capacity 
  24,138.00 
Total 
  471,791.00 
*Arithmetic comes out differently as decimal values are not shown in the table. 




6.4 STUDY IV 
By the close of 2018, the HND RCT had recruited and randomized 119 patients, eight had died, 
five had been excluded for clinical reasons, 59 were randomized to HND care, and 47 to stand-
ard care. Of the randomized 106 patients, 23 female patients were 76 years old, and the 83 male 
patients averaged 74 years old. Within the standard arm, 29 patients chose to cross over to 
HND care after one year, and one patient randomized to the HND arm decided to cross over to 
traditional care. 
6.4.1 Results of the cost analysis 
The frequencies of clinical events within each of the CDVCs for all three outpatient centers are 
provided in Appendix 2. The durations of each HCP’s involvement in the steps within each 
activity’s process map are provided in Appendix 3. The cost of each HCP, and the calculations 
for their corresponding CCRs are provided in Table 7. Other costs are presented in Table 8, 
and the rates at which they were adjusted down to account for costs incurred by non-HND 
patient visits are presented in Table 9.  
 
Table 7: HCP costs and CCRs 
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[(C ÷ I) ÷ 60] 
CCR  
(€/ min) 
 USK 3,645.00 0.70 2,553.00 0.50 212 106.8 38.25 6.65 710 0.06 
HND Cen-
ter RN 26,149.00 2.48 64,887.00 1.78 212 378.3 37.00 6.40 2421 0.45 
 MD 43,082.00 1.00 43,082.00 1.00 212 212.0 40.00 7.00 1484 0.48 
 USK 30,818.00 1.16 35,722.00 0.97 212 205.8 38.25 6.65 1369 0.43 
Nephrology 
Clinic RN 38,951.00 9.18 357,759.00 7.69 212 1631.1 37.00 6.40 10439 0.57 
 MD 43,082.00 1.00 43,082.00 1.00 212 212.0 40.00 7.00 1484 0.48 
Cardiology 
Clinic RN 35,052.00 7.21 252,884.00 6.10 212 1293.7 37.00 6.40 8280 0.51 





Table 8: Non-HCP costs 
Facility  Resource Monthly resource cost € Driver 
HND Center 
 Facilities 13,606.00 0.04 €/min/Sqmtr 
 Radiology 2,409.00 visits 
 Clinical Chemistry 3,232.00 physician visits 
 Physiology 1,913.00 visits 
 Immaterial costs 329.00 visits 
Kidney Clinic 
 Facilities 99,772.00 0.29 €/min/Sqmtr 
 Radiology 9,662.00 visits 
 Clinical Chemistry 23,301.00 physician visits 
 Physiology 8,145.00 visits 
 Other lab costs 10,381.00 physician visits 
 Pharmaceuticals 10,610.00 visits 
 Immaterial costs 9,777.00 visits 
Cardiology Clinic 
 Facilities 42,417.00 0.12 €/min/Sqmtr 
 Radiology 14,650.00 visits 
 Clinical Chemistry 7,863.00 physician visits 
 Physiology 35,397.00 visits 
 Immaterial costs 1,525.00 visits 
 
Table 9: Non-HCP cost adjustments 
Facility Driver RCT visit count Setting visit count Cost adjustment 
HND Center Physician visits 66 328 20.12% In-person visits 845 2,904 29.10% 
Kidney Clinic Physician visits 4 3387 0,12% In-person visits 7 8,875 0,07% 
Cardiology Clinic Physician visits 14 3316 0,42% In-person visits 38 6968 0,54% 
 
The total cost per day for each of each CDVCs is presented in Table 10, together with total 
patient exposure, cost per day exposure, and care utilization frequencies. For all patients, the 
first year of care following randomization was more expensive than the second. Patients that 
had crossed over to HND care were less expensive than both years of patients in the HND care 
arm.  
The number of patients that experienced care within each of the six CDVCs, and the corre-
sponding number of exposure days experienced by all patients is provided in  Table 10. Only 
one patient crossed over to Standard care from HND care, and this patient did not experience 
any visits. At least 25 patients experienced care in the other CDVCs, except for the second year 
of traditional care, where 10 patients experienced care. The unadjusted frequencies of the four 




Table 10: CDVC costs, patient exposure, and care utilization 
     Visits outside the defined CDVC 
CDVC 
Total TDABC 





















HND 1st yr 19,580.00 40 7,483 2.60 199 4 6 1 
Traditional 1st yr 1,856.00 30 6,475 0.29 134 157 13 5 
HND 2nd yr 23,561.00 46 11,088 2.12 94 111 29 4 
Traditional 2nd yr 84.00 10 1,651 0.51 17 54 7 3 
HND crossed to traditional 0.00 1 365 0.00 10 0 0 0 
Traditional crossed to HND 14,953.00 27 7,564 1.98 161 212 18 8 
         
All HND care 58,094.00 113 26,135 2.22 454 327 53 13 
All traditional care 1,941.00 41 8,491 0.23 161 211 20 8 
 
Three of the four care utilization variables – hospitalizations, hospitalization days, primary care 
visits, and inpatient visits – all tested positive for overdispersion and zero inflation. Hurdle 
models were used to compare these variables between HND and traditional care. The emer-
gency visit data was not over dispersed or zero inflated, and therefore a Poisson model was 
used for the comparison of emergency visit rates between HND and traditional care. All GLMs 
compared a care utilization variable between HND care and traditional care, and controlled for 
duration of exposure, and the proportion of a patients’ duration that was second year exposure. 
The results of the four GLM comparisons is presented in Table 11. There was a statistically 
significant decrease in hospital days and emergency visits when transitioning within the GLM 
from traditional care to HND care. There was no significant difference between the two groups 
with respect to primary care visits or inpatient visit frequencies. 
Patients in the HND arm, experienced 327 hospital days and 13 emergency visits over an ex-
posure duration of 26,135 days, which amounts to 4.57 hospital days and 0.78 emergency visits 
per year. The hurdle model applied to hospital days generated a coefficient of 1.77083182 
which was exponentiated to an odds ratio of 5.17. Thus, when compared to patients receiving 
HND care, the odds of experiencing hospital days for patients receiving traditional care was 
5.17 times that of HND patients. With a coefficient of 1.327589, the Poisson model applied to 
ED visits estimated that the odds of patients within traditional care processes experiencing an 
ED visit was 3.77 times higher than that of patients exposed to HND processes. Traditional 
care is thus estimated to experience 23.63 hospital days and 2.94 emergency visits in one year. 
The TDABC cost analysis estimated that HND care comes at an added cost of 1.99 € per day, 
which comes out to 726.85 € per year per patient (Table 12). The cost of an emergency visit 
and a hospital day are 450.00 € (Karolinska University Hospital, 2019) and 254.62 € (Adam et 
al., 2003), respectively, and thus one year of HND patient care saves the hospital 5,098.00 €.  
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Table 11: General linear model results 
Response Model Predictor Odds Ratios (CI) p-Value 
Inpatient bed days     
 Count model    
  count group 5.17 (1.88-15.1) 0.0026** 
  count duration 0.99 (0.96-1.01) 0.3017 
  count proportion2ndYr 0.91 (0.69-1.19) 0.4991 
 Zero hurdle model    
  zero (Intercept) 0.03 (0.00-0.58) 0.0212* 
  zero group 1.16 (1.77-1.50) 0.7408 
  zero duration 1.01 (1.00-1.03) 0.0653 
  zero proportion2ndYr 0.89(.72-1.09) 0.2705 
Primary care visits 
    
 Count model    
  count group 1.12 (0.57-2.20) 0.7435 
  count duration 1.00 (0.99-1.01) 0.8208 
  count proportion2ndYr 1.10 (0.97-1.25) 0.1336 
 Zero hurdle model    
  zero (Intercept) 0.06 (0.01-0.53) 0.0121* 
  zero group 2.34(0.98-5.59) 0.0551 
  zero duration 1.01 (1.00-1.01) 0.0205* 
  zero proportion2ndYr 1.37 (1.02-1.83) 0.0347* 
Inpatient visits 
    
 Count model    
  count group 1.38 (0.44-4.28) 0.5795 
  count duration 0.99 (0.97-1.01) 0.5217 
  count proportion2ndYr 0.64 (0.37-1.11) 0.1101 
 Zero hurdle model    
  zero (Intercept) 0.03 (0.00-0.58) 0.0212* 
  zero group 1.16 (0.49-2.74) 0.7408 
  zero duration 1.01 (1.00-1.01) 0.0653 
  zero proportion2ndYr 0.89 (0.721.09) 0.2705 
ED visits 
    
 Poisson model    
  group 3.77 (1.48-11.53) 0.0096** 
  duration 1.01 (1.00-1.02) 0.1678 
  proportion2ndYr 0.87 (0.62-1.08) 0.3024 






























HND care 810.86 4.57 0.78 1,163.61 351.00 2,325.47 
Traditional 
care 
84.01 23.63 2,94 6016.67 1323.00 7,423.68 







While the first published application of TDABC in health care was in 2009 (Demeere et al., 
2009), TDABC gained global attention in 2011 when it was highlighted in a Harvard Business 
Review (HBR) publication as the foundation of the solution to the cost crisis in health care 
(Kaplan and Porter, 2011). The article primarily called on providers to lead the initiative en-
couraging them to adopt a new approach to cost accounting and financial reporting. Following 
this publication, applications of TDABC spiked internationally. As detailed in the results of 
Study I of this thesis, the wave of publications that emerged confirmed the claims made in the 
HBR article reporting on the method’s accuracy, simplicity, and informative contributions to 
decision making. This thesis demonstrates how TDABC can be applied to capture and compare 
costs of processes for patients with multiple chronic conditions.  
More broadly, this thesis demonstrates how to conceptualize and evaluate real-world care path-
ways for patients with multiple chronic conditions in order inform actionable changes to clini-
cal management within hospitals. It lays the groundwork for empowering hospitals and other 
providers to incorporate financial analyses into their evidence development and decision mak-
ing, and to contribute to the wider financial and economic systems in health care. 
Specifically this thesis establishes a firm understanding of the relevant existing literature re-
garding how to bets apply a promising progressive costing system (Study I), characterizes care 
utilization within traditional and IMD-Care delivery models for MCC patients (Study II), and 
adapts and applies TDABC on traditional and IMD-Care processes (Study III and IV). The 
practical implications for bringing these findings into practice will then be presented and dis-
cussed in order to prepare health care professionals, finance directors, and clinic, department 
and hospital managers for how best to make use of the results and apply them in their organi-
zation.  
7.1 COUNTING WHAT DOESN’T COUNT 
Thus far, applications of TDABC in health care have made a great contribution to the literature 
base in describing experiences and identifying some practical lessons when applying TDABC 
in health care (Study I), but they fall short of achieving the wider goals of the seven-step ap-
proach. TDABC was invariably praised in the published literature for its accuracy and simplic-
ity. However, these applications have also solidified the existing inherent mismatch between 
our health care system and the needs of the modern patient. The fragmented nature of the health 
care system combined with the care pathway data requirements of TDABC bound the wave of 
applications to cost well-standardized and non-chronic conditions. 
If the data requirements and steps involved in TDABC applications are considered, it makes 
sense to focus on a well-standardized condition whose treatment has a clearly defined start and 
endpoint. The entire care pathway, together with all inherent processes, resources, and time 
estimates must be documented and analyzed. When care delivery requirements for MCC pa-
tients are considered, it immediately becomes clear that the task is not feasible. As a result, 
TDABC cost applications have yielded to the nature of the reductionist health care system, and 
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perpetuate the siloed, single treatment, single condition, single cause mindset. Applications of 
TDABC have not addressed the major challenges of costing care for modern patients, and the 
cost crisis continues (Study I). 
The key finding of the literature review was that while some steps can be taken to optimize 
TDABC applications, its ability to capture cost of medical conditions and CDVCs as intended 
remains to be demonstrated. Given that MCC patients are driving system-wide increases in 
health care costs, if TDABC is to contribute to solving the cost crisis, it must be capable of 
costing coordinated care designed to treat an interrelated set of patient circumstances including 
complications and comorbidities. This challenge relates specifically to the first two steps, and 
begs the question how can an MCC patient’s condition be defined, and how can the corre-
sponding CDVC be characterized? 
7.2 MEDICAL CONDITIONS WITH HIGH VARIATION AND HIGH-VOLUME:   
PATIENTS WITH MULTIPLE CHRONIC CONDITIONS 
The experiences of MCC patients within the health care system are characterized by variation 
and high frequency (OECD, 2011, Fortin et al., 2007), and HND patients are no exception 
(Study II). Defining a CDVC that spans the care pathway is clearly a barrier that needs to be 
broken in the context of a medical condition which requires coordinated care to treat interre-
lated patient circumstances including comorbidities. Study II in this thesis provided the scope 
and complexity that characterizes HND patient care clinically and geographically. Prior to be-
ing recruited to the HND study, patients experienced an average of seven outpatient visits, a 
primary care visit, a visit to the emergency room, and five days in the hospital every month. 
These patients also had a median of 14 diagnoses, and comorbidity score of five on the six-
point scale of the Charlson Comorbidity Index (Charlson et al., 2008, Charlson et al., 1987).  
The care experience associated with a condition of this intensity and complexity is perhaps best 
portrayed in Figure 4. The figure is the output of a process mining software, Disco (Fluxicon 
BV, 2020). The EHR data (Qlikview data) of HND patients was uploaded to the software which 
depicted all possible care pathways as they existed in practice, presenting the multitude of pa-
tient paths taken between different settings within one hospital. It quickly becomes clear why 
clinical providers have struggled to create standards of care for MCC patients. This is likely a 
large part of the reason why the literature review identified no study attempting to costing care 
for MCC patients.  
As an IMD-Care center, the HND Center works to assess each individual patient’s needs, and 
steer the care pathway specific for that patient, guided by available standards that apply to each 
comorbidity. One objective of the HND Center was to integrate care and reduce unnecessary 
health care visits in order to manage the unstable care seen in Figure 4 using the workflows 
presented in Figure 1. Intrinsic to the HND Center’s IMD-Care approach is a switch in the way 
of thinking away from care standardization to evidence-informed collaboratively generated 





Figure 4: Characterization of the HND clinical experience 
This figure is the result of plugging one year of time-stamped EHR (Qlikview) data for 314 HND     
patients into a process mining software called Disco (Fluxicon BV, 2020). Each line represents a 
unique path that multiple patients can follow over time, and the rectangles represent different           
locations at the hospital the patients encounter. If all patients followed the same care pathway, there 
would be only one path. 
 
7.3 TDABC APPLIED: COSTING CARE WITH HIGH VARIATION 
The lessons accrued in this thesis and its four individual studies provide a firm foundation for 
how hospital financial departments and managers of patient flows, units and clinics can cost 
care pathways for patients with complex care needs. The following section draws upon the 
collected results of the four studies and this thesis to present a strategy for TDABC application 
for costing complex care processes with high degrees of variation. It is most likely even appli-
cable when care processes are less complex, which is why efforts have been made to establish 
a common language and adopt an inclusive approach.  Robert Kaplan, the co-founder of both 
TDABC (Kaplan and Anderson, 2004, Kaplan and Anderson, 2007) and the seven-step health 
care approach (Kaplan and Porter, 2011), was a reviewer the study upon which this method 
was developed (Study II), and he recommended the manuscript for publication. 
7.3.1 Step 1) Define the medical condition 
Careful attention should be paid to defining the medical condition for patients with a specified 
set of chronic conditions. The definition must go beyond a set of named conditions lumped 
together. A group of relevant specialists should join as an IMD-Care team, perhaps as an IMD-
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Care center, to provide the clinical justification for combining care for a carefully selected set 
of chronic conditions. The team should provide explicitly formulated clinical requirements for 
inclusion in the patient group. As these conditions are chronic, a time period must be set for 
the cost analysis, for example one year (Studies III and IV). 
7.3.2 Step 2) Define the CDVC 
One major contribution of this thesis is the ability to cost clinical conditions in the absence of 
a standard CDVC (Study III). This is done through the modification of the second step of 
TDABC, moving from defining a standard CDVC, to statistically characterizing the non-stand-
ardized CDVC as it exists in practice. IMD-Care mitigates two challenges inherent to this mod-
ified approach: 1) high variation, the number of pathways occurring among patients, and 2) 
process instability, the constancy of processes over time (de Bruin et al., 2012). In the absence 
of IMD-Care, MCC patients would experience more variation instability, compromising the 
consistency of per-patient-cost estimates based on visit frequencies (Study III). IMD-Care cen-
ters stabilize care delivery, and coordination between settings eliminates some level of varia-
tion within the care processes. This statistical stability in care delivery allows for the 
characterization of the CDVC, and thus the costing of non-standardized care. 
As in Step 1, the CDVCs should be defined by a group of relevant specialists. Ideally, the 
CDVC should broadly incorporate all activities involved in treating the medical condition in-
cluding, for example, inpatient visits, emergency care, and perhaps primary care. This is yet to 
be achieved in the published literature for MCC patients and remains as a challenge for future 
research. In this thesis, the hospital lacked the information systems and data required to make 
a comprehensive analysis feasible, and care utilization measures were used in place of TDABC 
cost estimates to approximate the wider economic impact beyond the outpatient centers (Study 
IV). 
7.3.3 Steps 3) and 4) Develop process maps and estimate the time of         
activities 
Steps 3 and 4 are merged to form a single process mapping step. To avoid developing excess 
methodologies, and to maintain fidelity to the original seven-step approach to TDABC for 
health care, they are not reduced to a single “Step 3”. 
7.3.3.1 Step 3-4a) Assess the validity of available process data 
Many hospitals collect some form of process data for DRG costing purposes (Busse et al., 
2013), and some hospitals collect detailed process data that could suffice for a TDABC analy-
sis. In order to be sufficient for a TDABC analysis, maps must exist for all activities defined in 
the CDVC. These maps should be complete with process steps, the location of the activity, 
resources used in the process steps, and their duration of use (Studies III and IV).  
Existing process maps should be assessed for their suitability in a TDABC analysis. Process 
owners – the HCPs who are responsible for the activity – should review the validity of time 
estimates including how they were collected, how stable processes are expected to be, and the 
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amount of time that has passed since the maps were developed. It is important to note if time 
estimates were made from direct observation, reporting from HCPs, or estimates from stand-
ards. Observations are most reliable, and guidelines least. Based on the assessment of the qual-
ity of process data, new process data may need to be collected. 
7.3.3.2 Step 3-4b) Collect observational data of care processes 
If existing process data are not available, process data should be collected through direct ob-
servations by process owners with the support of controllers and operations staff (Studies III 
and IV). RFID has been discussed as an automated alternative (Kaplan and Porter, 2011), but 
has not been reported empirically in the published literature. As an external analyst or re-
searcher, collecting process data is inefficient because they are not familiar with existing prac-
tice. Instead, process owners should be identified, and assigned to collect observational process 
data with the support of quality management and process improvement staff. Data should be 
collected using a standardized electronic device that will minimize data entry error, and that 
can be uploaded to a database for smooth incorporation into a cost-accounting system. The 
process steps, the location, resources used, and their duration of use should be collected for 
each activity. Multiple observations should be made to improve the accuracy of estimates, and 
to allow for statistical analysis. 
7.3.3.3 Step 3-4c) Build process maps and validate them with health care professionals 
The construction of process maps from the uploaded data should be automated, requiring no 
additional work from hospital HCPs (Studies III and IV). HCPs should be able to upload their 
data, and immediately view the resulting maps for validation with their colleagues. Any adjust-
ments should be made based on their clinical experience before finalizing the process maps. 
7.3.3.4 Step 3-4d) Monitor process stability and update accordingly 
Processes that are likely to remain stable could be updated less frequently, but less stable pro-
cesses should be updated more often. Process owners should review their processes in standard 
intervals to look for those that are at risk of becoming outdated, paying special attention to less 
stable processes. 
7.3.4 Step 5) Estimate the cost of supplying patient care resources 
The annual cost of all resources should be obtained from the hospital’s economy department. 
Until standard or automated costing procedures are established, process owners and controllers 
should review the hospital’s chart of accounts to identify all direct, indirect, and support center 
costs required by the activities included in the CDVC (Studies III and IV). If the chart of ac-
counts is not very resolute, indirect and support center resources may need to be driven to 
activities on a volume bases as was done in this thesis – i.e. distributed evenly among appro-
priate activity types. However, if the chart of accounts is sufficiently detailed, support center 
resources can be allocated to direct costs such as HCPs or facilities space and added to the 
numerator of their capacity cost rate. This will generate much more accurate cost estimates. If 
the TDABC analysis is detailed enough, the cost of supplies can be included and should be 
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allocated to the activities in which they are used. The cost of supplies should include any costs 
required to make them available for patients, including storage and delivery (Kaplan and Porter, 
2011). 
The seven-step approach to TDABC calls for the mapping of support center processes as done 
in steps 3 and 4, using the sterilization of surgical equipment as an example (Kaplan and Porter, 
2011). However, this costing practice is yet to be described in the published literature. It would 
be useful to develop evidence detailing how this can be done empirically, but this exercise 
should be deferred until a functional TDABC system has been established. 
7.3.5 Step 6) Estimate the capacity of each resource, and calculate the      
capacity cost rate 
The concept of capacity should be carefully discussed with both HCPs and controllers to iden-
tify what datasets could be used to best estimate the capacity of resources active in the CDVC 
(Studies III and IV). For HCPs, information on FTEs from the chart of accounts or on HCP 
attendance from the scheduling system of the care center could be used to estimate capacity. 
Similar approaches can be taken for equipment. Careful attention should be paid to separate 
out time resources are not available for care delivery. The identified capacity datasets should 
be reviewed carefully to make valid practical capacity adjustments to resources, using the da-
taset that is most reflective of what happens in practice.  
The annual cost and practical capacity estimates of resources are used to calculate CCRs. One-
time-use supplies do not have a capacity, are allocated directly to activities.  
7.3.6 Step 7) Calculate the total cost of patient care 
The total cost of care is calculated by using the CCRs and process data to estimate the cost of 
all activities in the CDVC. The product of these costs and their corresponding annual mean 
frequencies is the annual cost of each activity in the CDVC. The sum of these annual costs is 
the total annual cost of the CDVC for the group of MCC patients (Studies III and IV).  
While a state-of-the-art information system would generate the most reliable cost estimates, 
these systems are rarely available and functional in practice. Room for flexibility and creativity 
should be allowed where information is left to be desired. In this thesis, a range of assumptions 
had to be made to achieve its aims.  
7.4 WHY KNOWING HOW TO COUNT IS NOT ENOUGH 
Without a holistic understanding of how TDABC-based costing system complements tradi-
tional approaches to hospital costing, the individual justifications for adopting such a system 
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can seem unclear and unconvincing on their own. The hospital in which this research was con-
ducted has a costing system that is viewed locally as an effective example to follow. In fact, it 
had a reputation in the region for the best cost estimates.  
The hospital contributes annual DRG cost estimates to a national DRG database and generates 
cost estimates for any given patient, department, or visit. Specifically, for HND care, the exist-
ing hospital costing system can estimate the cost of the HND Center, generate an approximate 
single cost applied to all HND outpatient visits, and estimate the annual cost for each HND 
patient. Clinical managers can understand how much they spend on traditional care versus 
HND care for HND patients, how much each patient costs in each setting, and how much a 
typical HND outpatient visit costs. From this information, a clinical manager can, if they want, 
know if they spend more on HND care than they do on traditional care per patient each year, 
and how much the HND Center costs the hospital. Management is appreciative of the infor-
mation coming out of the economy department, and managers have no incentive to modify a 
system that functions perfectly well. 
Even if management and HCPs were aware of the limitations of the existing costing system, 
they would likely not be concerned. HCP, pharmaceutical, and support center costs charged to 
the HND Center are all allocated evenly among outpatient visits within the clinic. This gener-
ates a single cost estimate for all outpatient visits in the cardiology clinic. Physician telephone 
consults and physician outpatient visits both cost the same amount. In 2017, the TDABC anal-
ysis estimated the cost of an HND telephone consult to be 60.00 € and a physician visit 297.00 
€ (Study III). The hospital lists all outpatient visits at the HND Center at 187.00 €. In the grand 
scheme of the budget for an entire clinic, these differences are miniscule and not worth inves-
tigating. Lab tests and radiology costs can be linked directly to patients, and when used together 
with visit costs, a reasonable cost estimate for patients can be made. The generation of more 
accurate visit costs is not appealing in and of itself. 
The advantages of TDABC become slightly clearer when considering new cost insights at the 
process level. In addition to distinguishing cost differences between different types of outpa-
tient visits, the TDABC system could depict where in processes each resource cost is incurred 
and its magnitude (Study III). From this information, clinical managers can understand how 
much is saved by substituting visits and resources within the care pathway and removing or 
shortening process steps where possible. They also get more accurate cost estimates of visits 
and patients. The benefits of activity and resource substitution decisions, however, are already 
apparent to providers. Physicians are aware that phone consults are less expensive than in-
person visits, and that nurse time is more affordable than physician time. It is perhaps not con-
vincing enough for managers to decide to overhaul cost-accounting infrastructure, when they 
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feel the information available is sufficient for economic decision making. However, the fol-
lowing section explains why this type of thinking is limiting.   
7.5 THE IMPACT OF COUNTING WHAT COUNTS 
It is not until TDABC systems are combined with strong research and development (R&D) 
internal to the organization, that the benefits of TDABC begin to demonstrate an impact that 
will capture the attention of hospital management. This is perhaps best discussed within the 
context of the VBHC framework. According to the VBHC literature, changes in both costs and 
outcomes over the entire care cycle need to be considered together in order to capture the value 
contribution of different interventions. The VBHC framework, however, often discusses com-
parisons between organizations, i.e. which organizations can provide the best outcomes at the 
lowest cost for a given condition. However, for decisions within organizations, simply knowing 
the outcomes achieved per unit cost when treating a condition is not productive because no 
alternative is available for comparison. Organizations must adopt internal research practices to 
assess changes in value before and after care interventions, or between different approaches to 
care delivery.  
In this thesis, a comparison was made based on an RCT performed within the hospital. TDABC 
generated the cost component of the value comparison of HND and traditional care, and the 
outcomes used in the analysis were care utilization parameters. Patients in the traditional care 
arm experienced more primary care and inpatient visits than patients in the HND arm. This 
difference is aligned with the program theory of the HND Center, but the coefficients associ-
ated with the odds ratios were not statistically significant. The odds ratios associated with the 
higher number of ED visits and hospital days seen in the traditional care arm were statistically 
significant (Study IV). This was also in line with the HND program theory. The analysis ulti-
mately found that the HND Center saved the hospital 5,098.00 € per patient treated at the HND 
Center through the reduction of hospital days and ED visits (Study IV). In 2018, the HND 
Center treated 403 patients, saving the hospital 2,054,494.00 €. For perspective, the hospital’s 
chart of accounts lists the HND Center at a cost of 573,389.00 € that year. In 2018, the tradi-
tional costing system estimated the cost of HND visit, kidney clinic visit, and cardiology clinic 
visit to be 198.00 €, 489.00 € and 244.00 € respectively. If these figures had been used to 
estimate the cost of HND care and plugged into the same RCT-based cost analysis, the esti-
mated cost savings of the HND program would have been 127.00 € per patient, or 51,272.00 € 
per year. This completely fails to capture the significant financial benefit of the HND Center, 
which is saving the hospital a few million Euro in added costs, and likely improving patient 
outcomes. If organizations begin to apply internal R&D initiatives in order to improve the ef-
ficiency of care delivery in terms of costs and outcomes, the consequences of having traditional 
costing will be problematic. 
The benefits of TDABC combined with R&D go deeper still. According to the traditional cost 
accounting system, the hospital spent 592,387.00 € in 2017 and 573,389.00 € in 2018, a 3.2% 
decrease. The 314 patients treated at the HND Center in 2017 increased by 28% to 403 in 2018, 
suggesting a decrease in the cost per patient from 1,887.00 € to 1443.00 €, a 23% decrease in 
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the cost per patient. The traditional accounting system also reported that HCP costs at the HND 
Center were 315,520.00 € in 2018, 1% higher than the 2017 cost of 310,942.00 €. It is likely 
that the hospital is not aware of this increase in efficiency, as the approach was simply to roll 
the 2017 budget over to 2018. The situation becomes interesting only when you observed 
through a TDABC lens. According to the TDABC cost analysis, the traditional costing figures 
are simply incorrect, and no longer relevant. The TDABC analyses show that the cost per pa-
tient per day of HND care decreased from 4.55 €to 2.20 € from 2017 (Study III) to 2018 (Study 
IV), a 52% decrease. However, the HCP cost per patient per day changed from 1.64 € in 2017 
to 1.12 € in 2018, a decrease of 32%. The HND Center used 52% fewer resources and 32% 
fewer HCPs to treat 28% more patients. This is a remarkable accomplishment, and one could 
become concerned that HCPs may be at risk of burnout. A deeper look shows that the propor-
tion of both new visits and team visits, which are both in-person visits involving both a doctor 
and a nurse, decreased substantially in 2018, as did nurse telephone consults. Even as in-person 
doctor visits and nurse-visits both increased in 2018, this cost was more than offset by the 
reduction in new visits and team visits. This is well aligned with the intendend workflow of the 
HND Center. As a lower proportion of patients are new, less require the initial new and team 
visits Figure 1. Essentially, as the HND Center becomes more established with a smaller pro-
portion of new patients, providers and patients settle into more efficient care delivery routines. 
The contribution of TDABC as compared to traditional become clear when the method is ap-
plied as it was intended: to solve the cost crisis by costing care across disciplinary boundaries, 
including comorbidities, which demands a change in how the CDVC is understood. Prior to 
this research, the hospital perceived HND as expensive using their usual costing approach. This 
research enabled them to see the savings generated by HND care, and management decided to 
continue with their support for the HND Center which has been able to continue its operations 
and spread the concept. 
7.6 THE CASE FOR INTEGRATED MULTIDISCIPLINARY CARE MODELS 
This thesis makes the case for IMD-Care centers because ineffective integrated care theory is 
moving practice in a counterproductive direction. It has long since been acknowledged that 
MCC patients generate the large amount of costs, that they are increasing in prevalence each 
year, and are of the highest priority to health care providers, managers, and policy makers 
(Clarke et al., 2017, Lehnert et al., 2011, OECD, 2011). Recent solutions have been to transition 
the coordination of care for these patients outside of hospitals, and into primary care where care 
delivery is less expensive (Boehmer et al., 2018, Coleman et al., 2009, de Bruin et al., 2012). 
For example, in Sweden, the government has commissioned a report, God Och Nära Vård 
(Quality Care Close to Patients), to develop an integrated care model similar to the Chronic 
Care Model and the Medical Home Model, with a clear focus on primary care. This initiative 
has a special focus on patients with complex conditions. While integrated care coordinated by 
general practitioners may be good for many patients (Coleman et al., 2009), this thesis high-
lights the flawed reasoning behind taking the most complex and difficult patients, moving them 
away from the providers with the most expertise in their treatment, and placing them in the care 
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of those educated to treat the general population in the most non-specialized setting. Instead of 
addressing the inefficiencies of the current specialist care reductionist system, which is expen-
sive because of the lack of coordination around the most expensive patients, the proposed so-
lution is to distance patients from the specialists they need. This has not generated an 
improvement in patient outcomes or a reduction in costs (de Bruin et al., 2012, Boehmer et al., 
2018).  
This thesis demonstrates that care coordination, backed by R&D and proper systems integra-
tion within the hospital organizations can lead to reduction in costs and care utilization. A team 
of specialists worked together to integrate care processes for complex patients, integrating ex-
pertise from their disease area, reduced the number of inpatient bed days and the number of 
emergency care visits. Patients with the option to choose HND or traditional care almost always 
choose HND care, and other research has shown that HCPs believe that HND care is the best 
approach to care for these patients (Even et al., 2019). Decision makers and clinical manage-
ment should consider shifting prioritization from moving integrated care to primary care and 
focus on reorganizing hospital care delivery to allow for specialists to work together with ad-
ministrative staff to align and coordinate care delivery for these patients.  
7.7 A NEED FOR COLLABORATION BETWEEN ECONOMY AND HEALTH 
CARE PROFESSIONALS 
Within the existing health care system, financial incentives and budget constraints incentivize 
administrative staff to focus on financial reporting. The Qlikview data was not usable within 
this TDABC analysis because policies were in place that dictated which visits should be re-
ported to Stockholm Region to support remuneration decisions. Cost estimates are calculated 
for DRGs annually to report to the Swedish National Board of Health and Welfare in order to 
maintain a national cost database for health economic analyses (Busse et al., 2013, Welfare, 
2007). Inconsistent costs are reported between institutions, which is problematic for health eco-
nomic analyses (Busse et al., 2013, Lindgren, 2014), and the focus of many DRG improvement 
initiatives is on how to make organizations report costs more consistently (Busse et al., 2013, 
Chapman et al., 2016). The heavy focus on reporting strains the work capacity of administrative 
staff towards reporting, and they have no time to look inwards within the organization to work 
with providers to improve care delivery (Chapman et al., 2016). Meanwhile, clinicians and 
managerial staff are informed of budget cuts on a semi-annual basis to which they must accom-
modate.  
Instead of prioritizing only event-based reporting in order to inform reimbursement and budg-
etary decisions, hospitals need to create space to prioritize data preservation and systems inte-
gration for internal managerial and clinical decision making. This will better enable hospitals 
to report more accurately, and better understand how to control costs for patients. A TDABC 
approach to costing, like the one used in this thesis, will equip managers with the tools to work 
with clinicians, justify costs, and demonstrate how to optimize outcomes for patients with the 
available resources.  
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8 METHODOLOGICAL CONSIDERATIONS 
8.1 THE CHALLENGE OF OBTAINING RELIABLE DATA  
Beyond the challenge of mitigating variation and stability in the CDVC, is the challenge of 
obtaining reliable data that accurately represent the patient experience. If data is unreliable, the 
CDVCs do not reflect care delivery, and the cost analysis is systematically compromised. If 
the data cannot be efficiently obtained and updated, the scalability of the cost analysis is com-
promised. The available datasets for estimating frequencies within the studies of this thesis 
were either unreliable or not digitally accessible. The Qlikview data that was initially obtained 
for frequency data in this thesis was assumed to be valid, but over time HCPs and researchers 
became suspicious of mismatches between the Qlikview data and clinical practice at the HND 
Center. After examining the data with controllers and HCPs, it was found that within the Qlik-
view dataset, repeat visits were consistently removed, canceled visits were removed even 
though they had required actions by providers, and non-billable events were removed. These 
changes all compromised the validity of a cost analysis, and therefore another alternative ap-
proach was chosen as described in the thesis. Datasets should therefore be carefully reviewed 
and well understood, so that process owners are confident they reflect work-as-done. The al-
ternative dataset used was the clinical journal data available in an old system called TakeCare. 
This data was not digitally available for manipulation and analysis even to HCPs at the hospital. 
As a result, the author and a nurse sat together to manually pull clinical event data from patient 
journals to obtain valid data for the analysis. Like CDVC data, process data is a difficult dataset 
to obtain. It is expensive to collect and is difficult to keep up to date. As in other hospitals, 
process data were collected annually for DRG costing initiatives. However, this data was not 
digitally available, and did not exist at all for the HND Center. All process data was manually 
collected within this thesis, and the methods for collecting these data were iteratively developed 
and piloted. 
Together with integrated multidisciplinary care, stronger information systems, and R&D com-
petencies, TDABC can meet the needs of today’s patients where traditional cost-accounting 
will fail. However, absent these added competencies, the approach taken in this research is 
currently not scalable from the HND Center to the rest of the hospital under current conditions. 
This need is not easy to demonstrate when existing cost accounting infrastructures continue to 
function as well as they always have.  
8.2 INTERPRETATION OF THE GENERAL LINEAR MODELS 
The general linear regression analyses in the Study IV are representative of the care utilization 
of HND patients during the 2018 year. While there is a statistically significant odds ratio with 
respect to inpatient visits and emergency visits, the 95% confidence intervals around these ra-
tios still imply a high likelihood of strong savings associated with HND care in 2018. It should 
also be noted that although this is what the data looked like in 2018, it is never certain how 
these predictions may play out in the future, especially with rare event data. 
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8.3 PERSONAL REFLECTIONS ON AN ACTION LEARNING JOURNEY 
The section below will elaborate on the lessons learned through the research process and the 
implications they may have for similar applications of TDABC in the health care context. I will 
begin writing in first person, as it is more appropriate for these reflections. 
Upon beginning the empirical research, I was content in my naïve notion that my comprehen-
sive academic understanding of TDABC had already empowered me to apply the method in 
real-world health care organizations. I was immediately humbled and found myself feeling 
confused and insecure. I had absolutely no idea where I was, what I was doing, and how my 
theoretical knowledge base should or even could be applied. I bounced between clinical pro-
viders, patient visits, fellow researchers, and hospital economic staff, iteratively looping 
through my own learning, struggling to build some semblance of a picture around how the 
organization functioned. During the first half (two years) of my time as an empirical researcher 
at the hospital, I felt completely unfamiliar with the organization and had no idea how much 
progress was being made. Evered and Louis (1981) describe this process as “groping in the 
dark” or “messy, iterative groping”.   
Change within an organization may only be achieved through experiencing and living the pro-
cesses and culture as you attempt to bring about change (Schein, 2010). I find this to be true, 
because I was unable to ask relevant questions until I had attempted to bring about change 
within the hospital. This two-year learning period was an iterative process through which I 
came to realize that the initial questions I had set out to answer were simply not relevant yet. 
They were too broad. Both myself and the organization were not yet prepared to ask the ques-
tion: “How can we cost integrated care at a hospital, and learn from our findings?” I first needed 
to identify the actual issues that were currently important barriers for the organization, a process 
that has been described as iterative and ever changing (Dutton et al., 1983). Some examples of 
issues I ran into included: 
1. How can we efficiently map care processes in a useful and productive 
way, and quickly? 
2. How can we understand, as researchers and clinicians, how costs are 
allocated within the cost accounting infrastructure? 
3. Why do different information systems at the hospital fail to reconcile 
properly, and what adjustments need to be made so that they do 
reconcile? 
4. Why is management reulctant to make needed changes in cost-
accounting systems in order to get a better understanding the cost of care 
processes? 
5. How can we help management to see the potential benefits and 
opporutnities to be gained if there is a willingness to change the way costs 
are approached, used, and understood? 
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Dutton et al. (1983) explain that the identification of issues such as those mentioned above is 
fluid, dynamic, and emergent. I found that boundaries are difficult to create around depart-
ments, staff, topics, or issues in an attempt to isolate them for the purpose of relevancy in prob-
lem solving. As a result, I became more and more drawn to attempting to understand the 
organization’s entire infrastructure. This was dynamic in that as my understanding deepened, 
and questions were slowly answered, my attention moved to newer and somewhat deeper is-
sues. My emerging understanding of these newer and deeper issues only came to light as other 
issues were solved or understood. 
As a researcher I sought to engage in practice but found myself to be mainly an outsider to the 
organization, particularly during the initial period.  During the first few years, I spent ten days 
in the hospital for observations, and then would travel to hospital meetings only a few times a 
term. Gaining access to needed information was often cumbersome. I had direct access to the 
lead physician at the HND Center. However, in consideration of the physician’s clinical obli-
gations, I needed to be respectful of his time as well as that of supporting staff. He was also 
often out of town, as he was working part-time to develop a similar system in Canada. Eco-
nomic staff were often slow to respond to my emails. In the early stages of getting acquainted 
with their staff, I found that the best way to gain access was to show up unannounced at the 
economics department with a data sharing contract to get the information I needed.  
Over time, and especially in the final years, I found myself at the hospital on almost a weekly 
basis. I began to feel as if I were a member of the organization. I had a contract signed by the 
hospital Chief Executive Officer (CEO) giving me access to the organization, its data, and its 
staff, and the CEO put the weight of her full support behind our initiative. It took some time, 
but I eventually delved deeply into what Schön (1995) refers to as the “swampy lowlands”, 
where the real “in-practice” problems became clear to me. For example, from the high grounds, 
estimating the actual cost of HND care was the main priority. However, once immersed in the 
context, I came to understand that, outside the HND Center, not everyone was invested in the 
importance of estimating the cost of HND care. Clinicians wanted to provide quality care to 
the patients they saw. Economists wanted to report up-to-standard financial information to 
management. Clinical heads wanted to increase budgets, so that they could provide clinicians 
with the tools they needed to provide quality care to patients. Management wanted to pull in 
more money from the regional government and figure out the best way to distribute those re-
sources fairly to the clinics based on the expressed needs of the clinical heads. The politics of 
the context almost completely overshadowed the objective of my research, and focus was 
needed for myself and my fellow researchers to stay the course. This was the core benefit of 
being an outsider, as described by Schön (1995) where I could objectively observe the organi-
zation and its workings from a distance. 
Political dynamics played a substantial role in how I thought and behaved throughout my pro-
ject. While my project was designed to understand how to implement TDABC to cost MCC 
patients, I knew also that I had been tasked with supporting an economic evaluation of the HND 
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Center. This could be understood as what Zuber‐Skerritt (2002) describe as the difference be-
tween “core” and “thesis” research. This also connects to the topic of role duality typical of 
empirical research projects, where the line dividing the role of researcher and organizational 
member begins to blur. I found myself in an ethical dilemma where I knew I should present 
my research objectively, however, I had to be careful at times how I presented my research. If 
it were misinterpreted or poorly received by individuals in key positions at the hospital, conse-
quences could immediately result that could negatively impact patient care. On multiple occa-
sions, I found inconsistencies within the hospital’s data, information systems, and 
infrastructure. I often had no way to identify which individual or group was responsible. If my 
reporting were to reflect badly on staff working within a related role, I knew I would have 
difficulty gaining their support thereafter. So, I had to tread carefully, walking a fine line to 
balance the need for staff to be comfortable with my reporting and the requirement that I convey 
my information in the most objective and correct way possible. Finally, I found that the HND 
Center was expensive as compared to traditional care, and I became concerned that if I reported 
my findings too soon, the HND initiative might be abandoned and the center closed. I could 
tell from my own observations that patients appreciated this new form of care. Furthermore, 
we had determined that HCPs working at the center believed this was the best way to treat 
patients (Even et al., 2019). I had to be conscious of my desire to protect the HND Center in 
order to keep a careful check on my confirmation biases, preventing them from influencing the 
costing analysis. This is the practice of knowing-in-action, being mindfully aware of my own 
tendencies to jump to conclusions due to emotional reasoning (Coghlan et al., 2015). A clear 
understanding of the cost-accounting tools and the theory behind the most innovative frame-
works is only the first step in preparing an organization for changing their cost infrastructures. 
Navigating the complexity of implementing a new and innovative approach within an organi-





Health care system improvement efforts are currently committed to regaining stability within 
a failing reductionist system that is not well-suited to the needs of today’s patients. The result-
ing inefficiencies have created cost and quality challenges for patients, providers, and systems. 
This thesis demonstrated that a hospital-based integrated multidisciplinary care approach to a 
complex medical condition makes economic sense for the hospital, the system, the HCPs, and 
importantly for the patient. The TDABC approach developed in this thesis project to cost care 
pathways for patients with multiple chronic conditions brings to light a set of elements which 
can be prioritized in future quality improvement efforts. In doing so, the thesis moves the fields 
of clinical management, clinical quality improvement, and cost-accounting in health care a step 
forward by identifying a set of core capacities that can be developed in health care organiza-
tions to make wiser decisions about integrated and interprofessional care. 
IMD-Care should be broadly incorporated into hospital service delivery. The process can be 
initiated by leveraging the competencies of specialists to identify medical conditions and in-
clusion criteria. When necessary, IMD-Care teams can take responsibility for the care of pa-
tients with pertinent conditions, by developing focused IMD-Care centers to manage person-
centered care. Over time, the case mix presenting to the hospital should be reviewed regularly 
to ensure that existing IMD-Care centers are in sync with the dynamics of the case mix over 
time. To that end, AI approaches that are currently under development could prove valuable as 
our information systems improve (Rafiq et al., 2019).  
Information systems need to be developed to include three capacities. First, standard routines 
need to be developed for the collection of process data. This includes the allocation of a certain 
proportion of staff time to quality improvement work in order to generate necessary datasets 
for core processes. Second, a relational database with standard data definitions must be devel-
oped that integrates process, event, cost, and clinical data across a unified platform. This chal-
lenge must include dedicated IT staff devoted to database management and development. 
Finally, an analytical tool should be developed or acquired that generates patient-specific, inter-
locational, and useful value-based information for clinicians and managers. The adapted 
TDBAC approach described in this thesis is a viable costing method to identify system ineffi-
ciencies, economic implications, and financial improvements (as well as process improvement 
opportunities) if these supporting other core capacities are developed. 
Research and Development competencies will need to be developed internally within hospitals. 
These competencies are crucial for well-designed interventions that will boost the actionability 
of information as it emerges from new information systems. Patient-safety, quality improve-
ment, and costing have traditionally been seen as separate competencies within hospitals, often 
working in separate silos. Instead, these competencies can be combined such that care teams 
within IMD-Care centers could be tightly coordinated with organizational R&D units to co-
develop interventions and studies. Sound scientific practice is crucial to ensure that quality 
information and evidence serve as the basis for action. 
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Through these core capacities, clinical organizations will hopefully become empowered to 
make wise, value-driven decisions that will serve as the new incentive for organizational im-
provement. Information that demonstrates value delivery will make financial needs clear to 
managers and policy makers, who in turn should understand that evidence-based investment in 
care facilities and services will ultimately demonstrate a return, benefiting not only IMD-Care 
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12 APPENDIX 1: SYSTEMATIC REVIEW SEARCH     
STRATEGIES 
 
Table 13: Search strategies for each journal 
Database Search strategy 
PubMed\MED-
LINE 
"time driven activity based cost*" OR "time-driven activity-based cost*" OR "TD-ABC" OR "TDABC" OR 
"time-driven activity based cost*" OR "time driven activity-based cost*" OR "time driven ABC*" OR  "time 
driven activity based cost*" OR "time-driven activity-based cost*" OR "TD-ABC" OR "TD ABC" OR "time-
driven activity based cost*" OR "time driven activity-based cost*" OR "time-driven ABC" OR "time-driven 
activity" 
WebOfScience  
"time driven activity based cost*" OR "time-driven activity-based cost*" OR "TD-ABC" OR "TDABC" OR 
"time-driven activity based cost*" OR "time driven activity-based cost*" OR "time driven ABC*" OR  "time 
driven activity based cost*" OR "time-driven activity-based cost*" OR "TD-ABC" OR "TD ABC" OR "time-
driven activity based cost*" OR "time driven activity-based cost*" OR "time-driven ABC" OR "time-driven 
activity" 
EMBASE 
("time driven activity based cost" OR "time-driven activity-based cost" OR "TD-ABC" OR "TDABC" OR 
"time-driven activity based cost" OR "time driven activity-based cost" OR "time driven ABC" OR  "time 
driven activity based cost" OR "time-driven activity-based cost" OR "TD-ABC" OR "TD ABC" OR "time-
driven activity based cost" OR "time driven activity-based cost" OR "time-driven ABC" OR "time-driven 
activity") AND ("time driven activity based costing" OR "time-driven activity-based costing" OR "TD-ABC" 
OR "TD ABC" OR "time-driven activity based costing" OR "time driven activity-based costing" OR "time 
driven ABC" OR  "time driven activity based costing" OR "time-driven activity-based costing" OR "TD-ABC" 
OR "TD ABC" OR "time-driven activity based costing" OR "time driven activity-based costing" OR "time-
driven ABC" OR "time-driven activity")  
OvidSP 
"time driven activity based cost*" OR "time-driven activity-based cost*" OR "TD-ABC" OR "TDABC" OR 
"time-driven activity based cost*" OR "time driven activity-based cost*" OR "time driven ABC*" OR  "time 
driven activity based cost*" OR "time-driven activity-based cost*" OR "TD-ABC" OR "TD ABC" OR "time-
driven activity based cost*" OR "time driven activity-based cost*" OR "time-driven ABC" OR "time-driven 
activity" 
Scopus 
"time driven activity based cost*" OR "time-driven activity-based cost*" OR "TD-ABC" OR "TDABC" OR 
"time-driven activity based cost*" OR "time driven activity-based cost*" OR "time driven ABC*" OR  "time 
driven activity based cost*" OR "time-driven activity-based cost*" OR "TD-ABC" OR "TD ABC" OR "time-
driven activity based cost*" OR "time driven activity-based cost*" OR "time-driven ABC" OR "time-driven 
activity" 
CINAHL 
"time driven activity based cost*" OR "time-driven activity-based cost*" OR "TD-ABC" OR "TDABC" OR 
"time-driven activity based cost*" OR "time driven activity-based cost*" OR "time driven ABC*" OR  "time 
driven activity based cost*" OR "time-driven activity-based cost*" OR "TD-ABC" OR "TD ABC" OR "time-
driven activity based cost*" OR "time driven activity-based cost*" OR "time-driven ABC" OR "time-driven 
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Database Search strategy 
activity" 
Science Direct  
(ALL("time driven activity based cost") OR ALL("time-driven activity-based cost") OR ALL("TD-ABC") OR 
ALL("TDABC") OR ALL("time driven activity-based cost") OR ALL("time-driven activity based cost") OR 
ALL("time driven ABC") OR ALL("time driven activity based cost") OR ALL("time-driven activity-based 
cost") OR ALL("time driven activity based costing") OR ALL("time-driven activity-based costing") OR 
ALL("TD-ABC") OR ALL("TD ABC") OR ALL("time driven activity-based costing") OR ALL("time-driven 
activity based costing") OR ALL("time driven ABC") OR ALL("time driven activity based costing") OR 
ALL("time-driven activity-based costing")) 
Google Scholar 
("time driven activity based cost*" OR TDABC OR "time driven ABC*" OR "TD ABC") AND (hospital OR 
hospitals OR health* OR Medicine OR Medical OR *Care OR clinic OR "Primary Care" OR "Practitioner" 





13 APPENDIX 2: CDVCS WITH VISIT FREQUENCIES 
 
Setting Process CDVC Visit count 
Kidney clinic 
Nurse phone consultation Traditional care year 2 1 
Physician phone consultation Traditional care 1 
Physician Visit Traditional care 3 
Physician Visit Traditional care crossed to HND 1 
Cardiology 
clinic 
Nurse phone consultation HND care 1 
Nurse phone consultation Traditional care crossed to HND 1 
Nurse Visit HND care 2 
Nurse Visit Traditional care 1 
Nurse Visit Traditional care year 2 2 
Nurse Visit Traditional care crossed to HND 2 
Physician phone consultation HND care year 2 1 
Physician phone consultation Traditional care 2 
Physician Visit HND care 1 
Physician Visit HND care year 2 3 
Physician Visit Traditional care 3 
Physician Visit Traditional care year 2 3 
Physician Visit Traditional care crossed to HND 4 
HND Center 
 
New Visit HND care 6 
New Visit HND care year 2 5 
New Visit Traditional care crossed to HND 9 
Nurse phone consultation HND care 93 
Nurse phone consultation HND care year 2 90 
Nurse phone consultation Traditional care 1 
Nurse phone consultation Traditional care crossed to HND 37 
Nurse Visit HND care 35 
Nurse Visit HND care year 2 48 
Nurse Visit Traditional care crossed to HND 15 
Physician phone consultation HND care 12 
Physician phone consultation HND care year 2 20 
Physician phone consultation Traditional care 1 
Physician phone consultation Traditional care crossed to HND 4 
Physician Visit HND care 19 
Physician Visit HND care year 2 32 
Physician Visit Traditional care 2 
Physician Visit Traditional care crossed to HND 13 
Team Conference HND care 19 
Team Conference HND care year 2 29 
Team Conference Traditional care crossed to HND 14 
Team Visit HND care 35 
Team Visit HND care year 2 25 





15 APPENDIX 3: PROCESS MAPS IN TABULAR FORM 
 
Department Process Resource Activity Minutes 
Cardiology 
Clinic 
New Visit Physician Post-consult chart update 11.15 
New Visit Physician Physician Consultation 25.89 
Physician Telephone consulta-
tion Physician Post call chart update 3.50 





Physician Visit Physician Physician Consultation 24.79 
Physician Visit Physician Post-consult chart update 8.58 
New Visit Physician Pre-consult preparation 7.00 
Team Visit Physician Physician Consultation 21.50 
Physician Telephone consulta-
tion Physician Telephone consultation 6.33 
Nurse telephone consultation RN Telephone consultation 6.88 
New Visit RN Nurse Consultation 14.00 
Nurse telephone consultation RN Post call chart update 2.33 
Nurse Visit RN Vitals 9.00 
Nurse telephone consultation RN Follow-up Scheduling 2.92 
Nurse Visit RN Nurse Consultation 28.10 
Team Visit RN Nurse Consultation 35.50 
Nurse telephone consultation RN Telephone consultation prepara-tion 2.33 
HND Center Physician Telephone consulta-
tion Physician Telephone consultation 7.00 
New Visit Physician Physician Consultation 39.00 
Physician Visit Physician Post-consult chart update 10.00 
Physician Telephone consulta-
tion Physician Post-consult chart update 10.00 
Team Visit Physician Post-consult chart update 10.00 
Nurse telephone consultation Physician Request support from physician 1.50 
Team Conference Physician Pre-conference preparation 15.00 
New Visit Physician Pre-consult preparation 9.00 
Team Conference Physician Team Conference 21.00 
New Visit Physician Post-consult chart update 10.00 
Physician Telephone consulta-
tion Physician Re-booked call prep 4.24 
Team Visit Physician Discussion to plan visit 3.00 
Physician Visit Physician Pre-consult preparation 5.00 
Team Visit Physician Pre-consult preparation 9.00 
Physician Visit Physician Physician Consultation 39.00 
Team Visit Physician Physician & Nurse consultation 45.00 
Physician Telephone consulta-
tion Physician Call-back 0.30 
Team Conference Physician Post-conference chart update 15.00 
Team Visit Physician Post-consultation discussion 1.50 
Physician Telephone consulta-
tion Physician Pre-consult preparation 5.00 
New Visit RN Nurse Consultation 45.00 
New Visit RN Follow-up Scheduling 5.00 
New Visit RN Post-consult chart update 10.00 
New Visit RN Pre-consult preparation 7.00 
New Visit RN Vitals 5.00 
Nurse telephone consultation RN Call-back 0.30 
Nurse telephone consultation RN Post-consult chart update 7.00 
Nurse telephone consultation RN Pre-consult preparation 5.00 
Nurse telephone consultation RN Re-booked call prep 4.24 
Team Visit RN Vitals 7.50 
Nurse telephone consultation RN Request support from physician 2.00 
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Department Process Resource Activity Minutes 
Nurse telephone consultation RN Second Telephone consultation 0.30 
Nurse telephone consultation RN Telephone consultation 7.00 
Nurse Visit RN Follow-up Scheduling 5.00 
Nurse Visit RN Nurse Consultation 45.00 
Team Visit RN Physician & Nurse consultation 45.00 
Nurse Visit RN Post-consult chart update 10.00 
Nurse Visit RN Pre-consult preparation 7.00 
Nurse Visit RN Vitals 5.00 
Team Conference RN Pre-conference preparation 1.00 
Team Visit RN Discussion to plan visit 3.00 
Team Conference RN Team Conference 14.00 
Team Visit RN Post-consult chart update 7.00 
Team Visit RN Post-consultation discussion 1.50 
Team Visit RN Pre-consult preparation 7.00 
Team Visit USK Follow-up Scheduling 12.50 
Physician Visit USK Follow-up Scheduling 12.50 
Physician Visit USK Vitals 15.00 
Team Conference USK Team Conference 7.00 
Kidney Clinic Physician Telephone consulta-
tion Physician Post-consult chart update 2.80 
Nurse Visit Physician Request support from physician 6.30 
Physician Visit Physician Post-consult chart update 6.60 
Physician Visit Physician Pre-consult preparation 3.30 
Physician Telephone consulta-
tion Physician Physician telephone consultation 3.40 
Physician Visit Physician Physician Consultation 21.10 
Nurse telephone consultation RN Request support from physician 2.60 
Nurse Visit RN Post-consult chart update 6.80 
Nurse Visit RN Pre-consult preparation 5.90 
Nurse telephone consultation RN Pre-consult preparation 2.40 
Physician Visit RN Pre-consult preparation 7.20 
Nurse telephone consultation RN Nurse Consultation 3.50 
Nurse telephone consultation RN Post-consult chart update 4.20 
Nurse Visit RN Nurse Consultation 44.90 
Nurse Visit USK Pre-consult preparation 7.50 
Physician Visit USK Follow-up Scheduling 7.50 
Physician Visit USK Vitals 9.50 
Nurse Visit USK Vitals 12.90 









16 POPULAR SCIENCE SUMMARY: COUNTING WHAT 
COUNTS IN HEALTH CARE 
It is difficult to ignore the discussion about how health care costs have been rising for decades 
and how most countries are forecast to increase national spending on health care through 2030. 
To put it bluntly, this is a problem. Health care resources are already spread thin, and providers 
are struggling to provide quality care under limited budgets. The consequences are felt through-
out society, as patients wait in long queues, are faced with higher deductibles, pay more out of 
pocket, or simply don’t get the care they need. To put things in perspective, Sweden spent 7% 
of its national budget on health care at the start of the century, and now spends 11%. The US 
has gone from 13% to 18% over the same period. 
At the core of this problem, ironically, is the fact that health care has substantially improved. 
People now survive chronic diseases longer than they used to; many survive long enough to 
develop multiple chronic conditions (MCCs). One in ten people has five or more chronic con-
ditions, and more than half the population has at least two. There are a range of other factors 
that drive rising costs including patient lifestyles and advances in technologies, but MCC pa-
tients require the bulk of health care resources. Health care policy makers, managers, and pro-
viders haven’t managed to find a way to mitigate rising costs, and they’ve been working at it 
for decades. This thesis has worked to get at the core of this problem and attempts to lay a path 
forward for health care managers, clinicians, and policy makers to consider. We feel that the 
secret to fixing this problem may lie within the combination of two ideas.  
The first idea is integrated multi-professional care within hospitals. Health care is divided into 
parts, where each part represents a field of medicine, like cardiology or pulmonology. These 
different parts all operate on their own, and don’t really work together much. Integrated care is 
a way of treating patients that brings together all the people and specialties that a patient with 
a certain type of condition can be expected to need in a coordinated, thought through manner.  
The second idea is a modern cost-accounting tool called Time-Driven Activity-Based Costing 
(TDABC). TDABC is a unique cost-accounting tool that is relatively simple to apply and ap-
propriate for costing care processes in health care but was difficult to apply to cost care for 
patients with multiple chronic conditions. This purpose of this thesis was to modify the TDABC 
costing approach for use on processes for patients with multiple chronic conditions, and then 
apply this modified method to cost care at an integrated multi-professional care center at a 
hospital.  
The impact was impressive. The integrated care center had been established to treat patients 
with heart disease, chronic kidney disease, and diabetes. The center demonstrated that it was 
beneficial for patients, and patients and providers were clearly satisfied with the results, in 
particular the patient-centered approach. However, the center appeared to be expensive under 
the existing (and less accurate) costing system. The TDABC analysis demonstrated that the 
Center was actually saving the hospital four times what it cost to keep the center in operation! 
The implications of these findings are profound, because this analysis was of a single center 
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that accounts for less than 1% of the hospital’s budget. If the hospital were empowered to make 
heavy cost savings like this on a regular basis, massive savings could be realized. We hope that 
this research can help hospitals to begin to invest in a few key elements that make this kind of 
analysis a success. These elements include integrated multidisciplinary approaches to chronic 
care, improved information systems in hospitals, and a time-driven activity-based costing tool 
to process data and deliver actionable information. 
 
 
 
